The current disclosure is directed to a general and modular mechanophore platform for a cargo molecule release via a mechanically triggered cascade reaction, and methods for the synthesis and use thereof.
Mechanical to chemical transduction is a powerful strategy for achieving materials with stimuli-responsive properties. The emerging field of polymer mechanochemistry aims to harness mechanical forces in polymers to promote productive chemical transformations in stress-responsive molecules known as mechanophores (see, for example: Beyer, M. K.; et al. Mechanochemistry: The Mechanical Activation of Covalent Bonds. Chem. Rev. 2005, 105, 2921-2948; Caruso, M. M.; et al. Mechanically-Induced Chemical Changes in Polymeric Materials. Chem. Rev. 2009, 109, 5755-5798; and Li, J.; et al. Polymer Mechanochemistry: From Destructive to Productive. Acc. Chem. Res. 2015, 48, 2181-2190; the disclosures of which are incorporated herein by reference). In such molecular systems, mechanical force is delivered to the mechanophores through covalently attached polymer chains using a variety of techniques, including solution-phase ultrasonication (see, for example: Berkowski, K. L.; et al. Ultrasound-Induced Site-Specific Cleavage of Azo-Functionalized Poly(ethylene glycol). Macromolecules 2005, 38, 8975-8978, the disclosure of which is incorporated herein by reference), tension or compression in solid materials (for example: Gossweiler, G. R.; et al. Mechanochemical Activation of Cova-lent Bonds in Polymers with Full and Repeatable Macroscopic Shape Recovery. ACS Macro Lett. 2014, 3, 216-219, the disclosure of which is incorporated herein by reference), atomic force microscopy (for example: Wu, D.; et al. Molecular Stress Relief through a Force-Induced Irreversible Extension in Polymer Contour Length. J. Am. Chem. Soc. 2010, 132, 15936-15938; and Sulkanen, A. R.; et al. Spatially Selective and Density-Controlled Activation of Interfacial Mechanophores. J. Am. Chem. Soc. 2019, 141, 4080-4085, the disclosures of which are incorporated herein by reference), laser-induced stress waves (for example: Grady, M. E.; et al. Shockwave Loading of Mechanochemically Active Polymer Coatings. ACS Appl. Mater. Interfaces 2014, 6, 5350-5355; and Sung, J.; et al. Interfacial Mechanophore Activation Using Laser-Induced Stress Waves. J. Am. Chem. Soc. 2018, 140, 5000-5003, the disclosures of which are incorporated herein by reference), and high intensity focused ultrasound (for example: Kim, G.; et al. High-intensity focused ultrasound-induced mechanochemical transduction in synthetic elastomers. Proc. Natl. Acad. Sci. 2019, 116, 10214, the disclosure of which is incorporated herein by reference). Mechanically coupled chemical activation has been demonstrated for a variety of covalent bond transformations to engender a wide range of functional responses, including changes in color or fluorescence (see, for example: Davis, D. A.; et al. Force-induced activation of covalent bonds in mechanoresponsive polymeric materials. Nature 2009, 459, 68-72; Imato, K.; et al. Mechanophores with a Reversible Radical System and Freezing-Induced Mechanochemistry in Polymer Solutions and Gels. Angew. Chem. Int. Ed. 2015, 54, 6168-6172; Wang, Z.; et al. A Novel Mechanochromic and Photochromic Polymer Film: When Rhodamine Joins Polyurethane. Adv. Mater. 2015, 27, 6469-6474; Göstl, R.; Sijbesma, R. P. π-extended anthracenes as sensitive probes for mechanical stress. Chem Sci 2016, 7, 370-375; Robb, M. J.; et al. Regioisomer-Specific Mechanochromism of Naphthopyran in Polymeric Materials. J. Am. Chem. Soc. 2016, 138, 12328-12331; and McFadden, M. E.; Robb, M. J. Force-Dependent Multicolor Mechanochromism from a Single Mechanophore. J. Am. Chem. Soc. 2019, 141, 11388-11392, the disclosures of which are incorporated herein by reference), chemiluminescence (for example: Chen, Y.; et al. Mechanically induced chemiluminescence from polymers incorporating a 1,2-dioxetane unit in the main chain. Nat. Chem. 2012, 4, 559, the disclosure of which is incorporated herein by reference), switching of electrical conductivity (for example: Chen, Z.; et al. Mechano-chemical unzipping of insulating polyladderene to semiconducting polyacetylene. Science 2017, 357, 475; and Yang, J.; et al. Benzoladderene Mechanophores: Synthesis, Polymerization, and Mechanochemical Transformation. J. Am. Chem. Soc. 2019, 141, 6479-6483, the disclosures of which are incorporated herein by reference), activation of catalysts (for example: Piermattei, A.; et al. Activating catalysts with mechanical force. Nat. Chem. 2009, 1, 133; and Michael, P.; Binder, W. H. A Mechanochemically Triggered “Click” Catalyst. Angew. Chem. Int. Ed. 2015, 13918-13922, the disclosures of which are incorporated herein by reference), and generation of reactive functional groups (for example: Hickenboth, C. R.; et al. Biasing reaction pathways with mechanical force. Nature 2007, 446, 423-427; Ramirez, A. L. B.; et al. Mechanochemical strengthening of a synthetic polymer in response to typically destructive shear forces. Nat. Chem. 2013, 5, 757-761; Robb, M. J.; Moore, J. S. A Retro-Staudinger Cycloaddition: Mechanochemical Cycloelimination of a β-Lactam Mechanophore. J. Am. Chem. Soc. 2015, 137, 10946-10949; Wang, J.; et al. Mechanochemical Strengthening of a Multimechanophore Benzocyclobutene Polymer. ACS Macro Lett. 2015, 4, 834-837; and Zhang, H.; et al. Mechanochromism and Mechanical-Force-Triggered Cross-Linking from a Single Reactive Moiety Incorporated into Polymer Chains. Angew. Chem. Int. Ed. 2016, 55, 3040-3044, the disclosures of which are incorporated herein by reference). Accordingly, continued advancement of this field is highly desirable, as new mechanophore discoveries and development will further expand the repertoire of mechanochemical function and will enable novel applications in organic materials.
Various embodiments are directed to a mechanophore platform including:
a mechanophore including
In various such embodiments, the furan includes at least one substituent at a position of the 2-furylcarbinol scaffold selected from a group consisting of: α-position, 3-position, 4-position, 5-position, and any combination thereof.
In still various such embodiments, the at least one substituent is an electron-donating functional group.
In yet various such embodiments, the at least one substituent is at at least one position selected from a group consisting of: 3-position, 4-position, 5-position, α-position, and any combination thereof; and wherein the at least one substituent is, each, independently selected from a group consisting of: alkyl, alkenyl, aryl, heteroaryl, any other aromatic or heteroaromatic functional group, alkoxy, aryloxy, amine, sulfide, any other heteroatom-containing group, including silane, a polymer chain of any composition, and any combination thereof.
In still yet various such embodiments, the at least one substituent comprises one of the combinations selected from a group consisting of: α-alkyl and the polymer at 5-position; 3-aryloxy and the polymer at 5-position; 5-aryloxy; α-alkyl, 3-aryloxy, and the polymer at 5-position; α-alkyl and 5-aryloxy; α-alkyl, 3-aryloxy, and 5-aryloxy; 3-aryloxy and 5-aryloxy; α-aryl and the polymer at the 5-position.
In various such embodiments, the dienophile is maleimide.
In still various such embodiments, upon release from the mechanophore platform, the cargo molecule displays a functionality selected from a group consisting of: alkyl alcohol, aryl alcohol, alkyl amine, aryl amine, carboxylic acid, and sulfonic acid.
In yet various such embodiments, the polymer includes a polymeric network of chains.
In various such embodiments, the polymer includes a surface instead of the at least one chain of the polymer covalently attached to the furan, or instead of the at least one additional chain of the polymer covalently attached to the dienophile, such that either the furan or the dienophile is immobilized on the surface.
In still various such embodiments, the polymer is selected from a group consisting of: polyacrylate, including poly(methyl acrylate); polymethacrylate, including poly(methyl methacrylate); polysiloxane, including polydimethylsiloxane; polyether, including poly(ethylene glycol); polyurethane; polyacrylamide; polyamide; polyester; and any combination thereof.
Various other embodiments are directed to a method for mechanochemically-gating release of molecular cargo including:
In various such embodiments, the furan includes at least one substituent at a position of the 2-furylcarbinol scaffold selected from a group consisting of: α-position, 3-position, 4-position, 5-position, and any combination thereof.
In still various such embodiments, the at least one substituent is an electron-donating functional group.
In yet various such embodiments, the at least one substituent is at at least one position selected from a group consisting of: 3-position, 4-position, 5-position, α-position, and any combination thereof; and wherein the at least one substituent is, each, independently selected from a group consisting of: alkyl, alkenyl, aryl, heteroaryl, any other aromatic or heteroaromatic functional group, alkoxy, aryloxy, amine, sulfide, any other heteroatom-containing group, including silane, a polymer chain of any composition, and any combination thereof.
In yet still various such embodiments, the at least one substituent comprises one of the combinations selected from a group consisting of: α-alkyl and the polymer at 5-position; 3-aryloxy and the polymer at 5-position; 5-aryloxy; α-alkyl, 3-aryloxy, and the polymer at 5-position; α-alkyl and 5-aryloxy; α-alkyl, 3-aryloxy, and 5-aryloxy; 3-aryloxy and 5-aryloxy; α-aryl and the polymer at the 5-position.
In still various such embodiments, the dienophile is maleimide.
In yet still various such embodiments, upon release from the mechanophore platform, the cargo molecule displays a functionality selected from a group consisting of: alkyl alcohol, aryl alcohol, alkyl amine, aryl amine, carboxylic acid, and sulfonic acid.
In yet various such embodiments, the polymer includes a polymeric network of chains.
In still various such embodiments, the polymer includes a surface instead of the at least one chain of the polymer covalently attached to the furan, or instead of the at least one additional chain of the polymer covalently attached to the dienophile, such that either the furan or the dienophile is immobilized on the surface.
In various such embodiments, the polymer is selected from a group consisting of: polyacrylate, including poly(methyl acrylate); polymethacrylate, including poly(methyl methacrylate); polysiloxane, including polydimethylsiloxane; polyether, including poly(ethylene glycol); polyurethane; polyacrylamide; polyamide; polyester; and any combination thereof.
In still various such embodiments, applying the mechanical force includes deforming the polymer.
In yet still various such embodiments, deforming the polymer is a method selected from a group consisting of: application of tension, compression, shearing, stretching, grinding, and any combination thereof.
In yet various such embodiments, applying the mechanical force is using ultrasound.
Additional embodiments and features are set forth in part in the description that follows, and in part will become apparent to those skilled in the art upon examination of the specification or may be learned by the practice of the disclosed subject matter. A further understanding of the nature and advantages of the present disclosure may be realized by reference to the remaining portions of the specification and the drawings, which forms a part of this disclosure.
These and other features and advantages of the present invention will be better understood by reference to the following detailed description when considered in conjunction with the accompanying data and figures, wherein:
The embodiments of the invention described herein are not intended to be exhaustive or to limit the invention to precise forms disclosed. Rather, the embodiments selected for description have been chosen to enable one skilled in the art to practice the invention.
Turning to the drawings, schemes, and data, embodiments of a modular molecular mechanophore platform for small molecule cargo release via a mechanically triggered cascade reaction are provided. In many embodiments, the mechanophore platform comprises a furan-dienophile Diels-Alder adduct and a cargo molecule covalently attached to the furan moiety of the Diels-Alder adduct, wherein the Diels-Alder adduct is flanked by polymeric chains or otherwise embedded into a polymeric network. In many embodiments, the furan moiety is a 2-furylcarbinol derivative, wherein the 2-furylcarbinol derivative is prone to decomposition via, presumably, although not to be bound by any theory, the corresponding transient furfuryl cation intermediate. Accordingly, in many such embodiments, mechanochemical activation of the mechanophore platform reveals the latent and unstable furan moiety via the retro Diels-Alder reaction, wherein the furan moiety, subsequently, decomposes, such as to release the cargo molecule. More specifically, in many embodiments, application of mechanical force to the mechanophore platform mechanochemically generates (i.e., unmasks) the furan moiety of the platform's Diels-Alder adduct and, thus, enables the decomposition of the platform with release of its cargo molecule. In many embodiments, various judicious substitutions of the furan moiety's 2-furylcarbinol scaffold and the cargo molecule attachment to the furan moiety allow to control the cargo molecule's release kinetics. In many such embodiments, the cargo molecule release from the mechanophore platform proceeds quickly under mild conditions, such as, for example, room temperature. In many embodiments, mechanical force alone is responsible for the “unlocking” of the unstable furan moiety of the mechanophore platform, wherein the mechanophore platform is otherwise chemically stable under similar chemical and physical conditions in absence of any mechanical stress. In many embodiments, the mechanical activation of the mechanophore platform is induced using ultrasound. In many embodiments, the functional scope of the cargo molecules that can be released from the mechanophore platform is highly general and broad. In many embodiments, the functionality of the released cargo molecules includes (but is not limited to): alkyl and aryl alcohols, alkyl and aryl amines, carboxylic and sulfonic acids. In some embodiments, the cargo molecule is a fluorogenic molecule, such as, for example, a coumarin derivative, wherein its release from the mechanophore platform allows for the facile tracking and quantification. In many embodiments, the mechanophore platform of the instant disclosure is useful in facilitating applications including, but not limited to: the mechanically triggered release of functional molecules in drug delivery, stress sensing, depolymerization, catalysis, self-healing materials, and other applications.
Polymers that release functional molecules in response to a specific stimulus, are desirable for a variety of applications including catalysis, sensing, self-healing materials, and drug delivery (see, for example: Swager, T. M. Sensor Technologies Empowered by Materials and Molecular Innovations. Angew. Chem. Int. Ed. 2018, 57, 4248-4257; Roth, M. E.; et al. Dendritic, Oligomeric, and Polymeric Self-Immolative Molecular Amplification. Chem. Rev. 2016, 116, 1309-1352; White, S. R.; et al. Autonomic healing of polymer composites. Nature 2001, 409, 794-797; and Patrick, J. F.; et al. Polymers with autonomous life-cycle control. Nature 2016, 540, 363-370, the disclosures of which are incorporated herein by reference). In this context, mechanically triggered release is particularly appealing, and, as such, several different approaches have been demonstrated, including physically entrapping payloads within a polymeric matrix (for example, Lee, K. Y.; et al. Controlled Drug Delivery from Polymers by Mechanical Signals. Adv. Mater. 2001, 13, 837-839, the disclosure of which is incorporated herein by reference), and the use of fluid-filled microcapsules or vascular networks (see Toohey, K. S.; et al. Self-healing materials with microvascular networks. Nat. Mater. 2007, 6, 581-585, the disclosure of which is incorporated herein by reference) embedded within a material that release their payload after being ruptured. Furthermore, the use of mechanical force as an external stimulus to drive covalent chemical transformations leading to a payload release has also emerged as an attractive strategy. In these recent developments, force is typically transduced via polymer chains attached to mechanically sensitive molecules (i.e., mechanophores) that respond in a chemoselective fashion, resulting in a productive chemical reaction. Such platforms could be useful, for example, in drug delivery applications, wherein, in the context of such applications, the activating force can be applied via ultrasound, which, in turn, is capable of penetrating deep within biological tissues to stimulate mechanochemical transformations noninvasively and with spatial and temporal precision (as described, for example in Kim, G.; et al. High-intensity focused ultrasound-induced mechanochemical transduction in synthetic elastomers. Proc. Natl. Acad. Sci. USA 2019, 116, 10214-10222, the disclosure of which is incorporated herein by reference). In light of these advantages, the field of polymer mechanochemistry has attracted significant interest for the design of autonomous materials that respond innately and specifically to mechanically dynamic environments, as well as abundant opportunities to advance fundamental understanding of mechanochemical reactivity, which is underdeveloped compared to other areas of organic chemistry (see, for example, Akbulatov, S.; Boulatov, R. Critical review of experimental polymer mechanochemistry and its interpretational frameworks. ChemPhysChem 2017, 18, 1422-1450, the disclosure of which is incorporated herein by reference).
Accordingly, several mechanophores have been designed to achieve mechanically triggered release of functional organic molecules. For example, molecular release from mechanophores has been achieved via mechanically triggered cycloreversion (for additional examples, see P. B. Jayathilaka, et al., Chem. Commun., 2021, DOI: 10.1039/D1CC02726C, the disclosure of which is incorporated herein by reference), rearrangement (for examples, see: Diesendruck, C. E.; et al. Proton-Coupled Mechanochemical Transduction: A Mechanogenerated Acid. J. Am. Chem. Soc. 2012, 134, 12446-12449; and Lin, Y.; et al. A Latent Mechanoacid for Time-Stamped Mechanochromism and Chemical Signaling in Polymeric Materials. J. Am. Chem. Soc. 2020, 142, 99-103, the disclosures of which are incorporated herein by reference), and various other cascade reactions (for examples, see: Z. Shi, et al., J. Am. Chem. Soc., 2020, 142, 14725-14732; Z. Shi, et al., Chem. Sci., 2021, 12, 1668-1674; S. Huo, et al., Nat. Chem., 2021, 13, 131-139; and Z. Shi, et al., CCS Chem., 2021, 2333-2344, the disclosures of which are incorporated herein by reference). However, the scope of molecules (payload) that can be released from the mechanophores reported to date is still relatively limited. For example, Moore and Craig have designed mechanophores based on gem-dichlorocyclopropane motifs that undergo mechanochemical rearrangement reactions with subsequent release of HCl. In addition, Boydston developed an oxanorbornadiene mechanophore that releases a benzyl furfuryl ether molecule via a mechanically induced cycloelimination reaction (Larsen, M. B.; Boydston, A. J. “Flex-Activated” Mechanophores: Using Polymer Mechanochemistry To Direct Bond Bending Activation. J. Am. Chem. Soc. 2013, 135, 8189-8192; and Larsen, M. B.; Boydston, A. J. Successive Mechanochemical Activation and Small Molecule Release in an Elastomeric Material. J. Am. Chem. Soc. 2014, 136, 1276-1279, the disclosures of which are incorporated herein by reference). Moreover, metal ion release from the mechanical dissociation of ferrocene was also recently demonstrated (see Di Giannantonio, M.; et al. Triggered Metal Ion Release and Oxidation: Ferrocene as a Mechanophore in Polymers. Angew. Chem. Int. Ed. 2018, 57, 11445-11450; and Sha, Y.; et al. Quantitative and Mechanistic Mechanochemistry in Ferrocene Dissociation. ACS Macro Lett. 2018, 7, 1174-1179, the disclosures of which are incorporated herein by reference). Nevertheless, each of these approaches uses a judiciously designed mechanophore to release a very specific compound upon mechanical activation, which, consequently, limits the scope of molecules that can be released. As another example, small molecule release has also been achieved through the mechanically triggered heterolytic scission and subsequent depolymerization of a unique metastable cyclic poly(ortho-phthalaldehyde) polymer to regenerate its constituent monomers (Diesendruck, C. E.; et al. Mechanically triggered heterolytic unzipping of a low-ceiling-temperature polymer. Nat. Chem. 2014, 6, 623-628; and Peterson, G. I.; Boydston, A. J. Kinetic Analysis of Mechanochemical Chain Scission of Linear Poly(phthalaldehyde). Macromol. Rapid Commun. 2014, 35, 1611-1614, the disclosures of which are incorporated herein by reference). In addition, most recently, Herrmann and Göstl have introduced a mechanophore design that relies on mechanochemical scission of a chain-centered disulfide unit and ensuing 5-exo-trig cyclization to release an alcohol attached via a β-carbonate linker. However, while the release of several different alcohols has been demonstrated using this disulfide mechanophore platform, it is susceptible to nonspecific activation via chemical reduction or thiol exchange and cargo scope is relatively limited (as explained by Shi, Z., et al. in The Mechanochemical Release of Naphthalimide Fluorophores from β-Carbonate and β-Carbamate Disulfide-Centered Polymers, CCS Chemistry 2021, https://doi.org/10.31635/ccschem. 021.202101147, the disclosure of which is incorporated herein by reference). Therefore, more modular and generalized mechanophore designs for the triggered release of functional organic molecules are needed to enable new opportunities for polymer mechanochemistry.
The concept of mechanically gated reactivity (see, for example, Wang, J.; et al. Mechanical gating of a mechanochemical reaction cascade. Nat. Commun. 2016, 7, 13433, the disclosure of which is incorporated herein by reference), wherein, for example, a cascade reaction is initiated by an external stimulus, such as, for example, mechanical stress, offer a unique and particularly useful approach for controlling molecular release, because, in such strategies, the mechanochemical reaction is generally decoupled from the ultimate functional response For example, externally triggered cascade reactions include retro-Diels-Alder reactions that serve as thermal triggers for, for example, the depolymerization of self-immolative polymers. In other examples, Boydston and coworkers reported a 1,2-oxazine linker (Peterson, G. I.; et al. 1,2-oxazine linker as a thermal trigger for self-immolative polymers. Polymer 2014, 55, 5980-5985, the disclosure of which is incorporated herein by reference), while Gillies and coworkers reported a furan-maleimide adduct—both capable of initiating a depolymerization cascade reaction at elevated temperatures (Fan, B.; et al. Thermo-responsive self-immolative nanoassemblies: direct and indirect triggering. Chem. Commun. 2017, 53, 12068-12071, the disclosure of which is incorporated herein by reference). The latter example invoked the thermal instability of a furfuryl carbonate, similar to the decomposition of furfuryl bromide that was first described by Zanetti and Bashour (Zanetti, J. E.; Bashour, J. T. α-Furfuryl Bromide (2-Bromomethylfuran). J. Am. Chem. Soc. 1939, 61, 2249-2251, the disclosure of which is incorporated herein by reference). As a more specific example of an external stimulus-gated reactivity, Branda and coworkers designed a photo-gated system, wherein a diarylethene photoswitch allowed for electronic conjugation between a remote electron donating group and a labile carbonate group to be modulated with light, resulting in fragmentation of the carbonate upon photochemical electrocyclization (Warford, C. C.; et al. From slow to fast—the user controls the rate of the release of molecules from masked forms using a photoswitch and different types of light. Chem. Commun. 2015, 51, 7039-7042, the disclosure of which is incorporated herein by reference). Moreover, the concept of mechanochemical gating to regulate a photochemical transformation, in which a mechanically facilitated retro-Diels-Alder reaction unmasked a diarylethene photoswitch, was also recently extended (see, for example: Hu, X.; et al. Mechano-chemical Regulation of a Photochemical Reaction. J. Am. Chem. Soc. 2018, 140, 14073-14077, and U.S. patent application Ser. No. 17/019,107, the disclosures of which are incorporated herein by reference). Overall, the mechanochemical gating paradigm offers a powerful approach for the design of highly modular platforms for release of functionally diverse molecular cargo, as the mechanochemical behavior of the mechanophore and the functional properties of the masked intermediate can be controlled independently.
This application is directed to embodiments of a modular mechanophore platform for release of a cargo molecule, and methods of synthesis and use thereof. In particular, the application is directed to embodiments of the macromolecular mechanophore platform comprising a furan-dienophile Diels-Alder adduct, wherein the furan moiety is a 2-furylcarbinol derivative covalently pre-loaded with a cargo molecule of choice, and wherein the Diels-Alder adduct is embedded into a polymeric chain or another polymeric network, such that it undergoes the retro [4+2] cycloaddition reaction under mechanical force to reveal the unstable, cargo molecule-carrying furan moiety. In many such embodiments, the furan moiety is a 2-furylcarbinol derivative prone to decomposition via the corresponding furfuryl cation resulting in scission of the α-C-heteroatom bond. In many such embodiments the furan moiety's 2-furylcarbinol scaffold is judiciously designed to spontaneously and quickly (or slowly, if desired) decompose, such as to release the cargo molecule. More specifically, in many embodiments, the 2-furylcarbinol scaffold of the furan moiety is substituted according to the guidelines provided in the instant disclosure to control (e.g., promote or impede) the furan moiety's decomposition and cargo molecule release kinetics. In many such embodiments, judiciously chosen substituents installed at positions: α-, 3-, and 5- of the 2-furylcarbinol scaffold, or any combination thereof, or substituents installed at other positions of the 2-furylcarbinol scaffold, promote the decomposition of the mechanophore platform and the release of the cargo molecule under mild conditions, such as for example, at room temperature, upon the mechanically triggered reaction cascade. Accordingly, in many embodiments, some of which are illustrated in
In many embodiments, the dienophile moiety of the Diels-Alder adduct of the mechanophore platform of the instant disclosure is any substituted alkene. In many such embodiments, the substituents on the substituted alkene are each independently selected from a group consisting of (but not limited to): H, halogen, alkyl, alkenyl, aryl, heteroaryl, alkoxy, alkylamine, carbonyl, a polymer chain of any composition. In some embodiments, the dienophile is an alkene selected from a group consisting of, but not limited to: acrylate, methacrylate, maleate, fumarate, and any other similarly substituted alkene. In some embodiments, the dienophile is a maleimide of any substitution.
In many embodiments, the furan moiety of the Diels-Alder adduct of the mechanophore platform of the instant disclosure is a 2-furylcarbinol derivative comprising a 2-furylcarbinol scaffold schematically depicted in
Nevertheless, the same DFT calculations indicated that substitution with an α-methyl group (FC3 in
As one particular example of the suitable furan moieties of many embodiments,
Nevertheless, while the furan moiety's substitution pattern of some embodiments, wherein the α- and 5-positions feature substituents, is sufficient to enable the release of a phenolic cargo molecule with a half-life of approximately 1 h, the rate of fragmentation is still prohibitively slow for some applications for, for example, alcohol-derived furfuryl carbonates and amine-derived furfuryl carbamates. For example,
Accordingly, in many embodiments, especially wherein the mechanophore platform of the instant disclosure needs to release a non-phenolic cargo, i.e., wherein the furan moiety is, for example, an alcohol-derived furfuryl carbonate or an amine-derived furfuryl carbamate, or another 2-furylcarbinol derivative, alternative and or additional substitution or substitutions of the 2-furylcarbinol scaffold is employed to further promote rapid and facile decomposition of the mechanophore platform and the cargo molecule release. More specifically, in many embodiments, an electron-donating substituent (see, for example, Schmid, K. M.; et al. A Self-Immolative Spacer That Enables Tunable Controlled Release of Phenols under Neutral Conditions. J. Org. Chem. 2012, 77, 4363-4374, the disclosure of which is incorporated herein by reference), such as, for example, phenoxy, or any other aryloxy, at the 3-position of the furan moiety is installed. Not to be bound by any theory, it is believed that such substituent further suppresses the activation barrier for fragmentation of the 2-furylcarbinol scaffold, since this substituent is in resonance with the furfuryl cation, and enables the efficient release of more challenging payloads, including amines (as explained, for example, in Nichol, M. F.; et al. Multi-stimuli responsive trigger for temporally controlled depolymerization of self-immolative polymers. Polym. Chem. 2019, 10, 4914-4919, the disclosure of which is incorporated herein by reference), under mild conditions. In other words, the incorporation of an electron donating substituent at 3-position of the furan heterocycle is believed to reduce the activation barrier for fragmentation of the α-C—X bond (
For example,
A similar trend in reactivity is observed for the furfuryl carbamate model series (FC(N)); however, calculated activation energies are 5.5-7.6 kcal/mol larger for the furfuryl carbamates compared to the analogous furfuryl carbonate substrates in all cases (
Furthermore, in many embodiments, the 3-phenoxy, or similar aryloxy, substituent on the furan moiety does not affect the mechanochemical properties of the mechanophore platforms of the instant disclosure. To demonstrate the mechanochemical stability of the mechanophore platforms comprising differently substituted furan moieties, DFT calculations were performed on model compounds M1 through M4 depicted in
However, notably, in many embodiments, the 3-phenoxy (or similar aryloxy at 3-position) substituent on the furan moiety does affect the thermal properties of the mechanophore platforms of the instant disclosure. For example,
Accordingly, in many embodiments, the furan moiety of the mechanophore platform comprises an electron-donating functional group at the 3-position. In some such embodiments, the electron-donating functionality at 3-position of the furan moiety is employed by itself, or in any combination of appropriate (as described herein) substituents at α-position and 5-position, to facilitate the release of the cargo molecule with the desired kinetics. In many embodiments, the substituent at the 3-position is a functional group selected from a group consisting of: alkyl, alkenyl, aryl, heteroaryl, any other aromatic or heteroaromatic functional group, alkoxy, aryloxy, amine, sulfide, any other heteroatom-containing group, such as silane, a polymer chain of any composition, and any combination thereof. In many embodiments, the 3-position substituent is phenoxy. In many embodiments, the 3-position substituent also serves as a linker/point for the attachment of the polymer component of the mechanophore platform.
As one example of the suitable furan moiety comprising the advantageous, electron-donating, 3-aryloxy substituent of many embodiments,
It should be noted here, that when the same decomposition of 21 was performed at significantly higher concentrations, another set of peaks was observed in the 1H NMR spectra of the reaction, corresponding to the formation of a side product, that was identified to be the furfuryl amine 24N, derived from nucleophilic attack of the furfuryl cation intermediate by liberated aminocoumarin 3:
A similar product/reaction was not observed for the furfuryl carbonates, highlighting the increased nucleophilicity of the amine cargo molecules. Importantly, however, this furfuryl amine side product is formed in <2% yield in reactions with a substrate concentration of 19 μM, which is similar to the concentration of mechanophores in typical ultrasonication experiments (vide infra). Therefore, the reaction depicted in
Furthermore,
Nevertheless, while, in some embodiments, an electron-donating substituent, such as, for example, phenoxy, at 3-position of the furan moiety enables release of challenging payloads, such as amines, on reasonable time scales, installation of such a group at the 3-position may be synthetically onerous and inefficient. Therefore, in some embodiments, other, more synthetically accessible substitution schemes and structural features are applied to the furan moiety, such that the developing positive charge at the α-position in the transition state of the decomposition process is stabilized, and, thus, the rate of the molecular cargo release from 2-furylcarbinol derivative is increased. In other words, in many embodiments, another substituent or substituents that increases the electron density of the furan moiety is employed to enable the rapid release of challenging cargo molecules (e.g., amines), instead of, or in addition to, any combination of, for example, α-methyl substituent (which reduces the activation barrier for fragmentation of its furan host by 3-4 kcal/mol, as compared to the primary 2-furfylcarbinol derivatives), and an electron-donating 3-phenoxy group (which reduces the activation barrier for fragmentation of its furan host by 4-5 kcal/mol, as compared to the 2-furylcarbinol derivatives without a 3-phenoxy group). In many such embodiments, the furan moiety comprises an electron-donating substituent, such as, for example, aryloxy substituent, at 5-position of the furan moiety, as illustrated, for example by 5-OAr(1°) in
Notably, in many embodiments, the introduction of the phenoxy substituent at the 5-position of the furan moiety preserves proximal pulling geometry on the Diels-Alder adduct mechanophore, which has been shown to result in greater mechanochemical activity compared to other regioisomers. Furthermore, DFT calculations using the constrained geometries simulate external force (CoGEF) method, illustrated by
In addition,
Accordingly, in many embodiments, the furan moiety of the mechanophore platform is a 2-furylcarbinol derivative, wherein the 2-furylcarbinol scaffold comprises an electron-donating functional group at the 5-position. In some such embodiments, the electron-donating functionality at 5-position of the furan moiety is employed by itself, or in any combination of appropriate (as described herein) substituents at α-position and 3-position, to facilitate the release of the cargo molecule with the desired kinetics. In many embodiments, the substituent at the 5-position is a functional group selected from a group consisting of: alkyl, alkenyl, aryl, heteroaryl, any other aromatic or heteroaromatic functional group, alkoxy, aryloxy, amine, sulfide, any other heteroatom-containing group, such as silane, a polymer chain of any composition, and any combination thereof. In many embodiments, the 5-position substituent is aryloxy. In many embodiments, the 5-position substituent also serves as a linker/point for the attachment of the polymer component of the mechanophore platform. In some such embodiments, attaching the polymer via the 5-position substituent increases mechanochemical activity of the mechanophore platform.
In some embodiments, the furan moiety of the mechanophore platform is a 2-furylcarbinol derivative, wherein the 2-furylcarbinol scaffold comprises an electron-donating, or another type of, a functional group at the 4-position. In some such embodiments, the substituent at 4-position of the furan moiety is employed by itself, or in any combination of appropriate (as described herein) substituents at α-position, 3-position, and 5-position, to facilitate the release of the cargo molecule with the desired kinetics. In many embodiments, the substituent at the 4-position is a functional group selected from a group consisting of: alkyl, alkenyl, aryl, heteroaryl, any other aromatic or heteroaromatic functional group, alkoxy, aryloxy, amine, sulfide, any other heteroatom-containing group, such as silane, a polymer chain of any composition, and any combination thereof. In many embodiments, the 4-position substituent is aryloxy. In many embodiments, the 4-position substituent also serves as a linker/point for the attachment of the polymer component of the mechanophore platform.
As one example of the suitable furan moiety comprising the synthetically and otherwise advantageous 5-aryloxy substituent of many embodiments,
Here, it should be noted that, while 2-furylcarbinol derivatives of many embodiments, wherein the 2-furylcarbinol derivatives comprise 3-H and 3-OPh substituents, as disclosed herein, decompose under the same conditions as used to obtain the data provided in
In many embodiments, the mechanophore platform comprises the furan-dienophile Diels-Alder adduct covalently embedded into a polymer, such as a single polymer chain or a polymeric network, wherein the attached polymer transmits the applied mechanical force to the mechanophore for activation. In some embodiments, the polymer is selected from, for example, a group consisting of: polyacrylates, including poly(methyl acrylate) (PMA), polymethacrylates, including poly(methyl methacrylate) (PMMA), polysiloxanes, including polydimethylsiloxane (PDMS), polyethers, including poly(ethylene glycol) (PEG), polyurethanes, polyacrylamides, polyamides, polyesters, and any combination thereof. In many embodiments, the polymer is at least two single chains of an approximately same length flanking the mechanophore such that one chain is attached to the portion corresponding to the dienophile moiety of the Diels-Alder adduct, the other chain is attached to the furan moiety of the Diels-Alder adduct, and the overall Diels-Alder adduct is positioned in the center of the whole construct. In such embodiments, application of external force, such as, for example, provided by ultrasonication, produces elongational/tensile forces maximized near the overall chain's midpoint, where the mechanophore Diels-Alder adduct is situated, and, thus, promotes mechanophore activation. In other words, the polymer chains judiciously attached to the Diels-Alder adduct mechanophore according to many embodiments are responsible for transmitting the applied mechanical force to the mechanophore moiety, making it undergo force-induced reactivity and break apart. In some embodiments, more than two polymeric chains are attached to the Diels-Alder adduct, as long as at least one chain is attached to each one—the furan and the dienophile moieties of the mechanophore platform of the instant disclosure. In some embodiments, the mechanophore platform is embedded into a force transmitting polymeric network. In many embodiments, the polymer is attached to the dienophile portion of the Diels-Alder adduct at any available position, including, for example, wherein the dienophile is a maleimide, at the nitrogen atom of the maleimide. In many embodiments, the polymer is attached to the furan moiety of the Diels-Alder adduct at any available or convenient position of the furan moiety's 2-furylcarbinol scaffold, either directly, or via any appropriate linker or linking moiety. In many embodiments, the polymer is attached to the furan moiety at 5-position of the 2-furylcarbinol scaffold, however, in some embodiments, the polymer is attached at any other position of the 2-furylcarbinol scaffold, including: the 4-position, the 3-position, or the α-position. In some embodiments, attaching the polymer at 5-position increases mechanochemical activity of the mechanophore platform. In some embodiments, the polymer is attached only to one of: the furan or the dienophile moieties of the mechanophore platform, while the remaining dienophile or furan moiety is otherwise immobilized, for example, by attachment to a surface.
Any method of mechanical force application can be used for activation of the mechanophore platforms of the instant disclosure, as long as the force can be transduced to the mechanophore with sufficient energy to induce the retro Diels-Alder reaction within the mechanophore and the mechanophore's breakage. In some embodiments, the mechanical force is provided by means of ultrasonication and is transduced to the Diels-Alder adduct moiety via the mechanophore's polymer chains flanking the Diels-Alder adduct. In some embodiments, the force is transmitted to the mechanophore embedded within a polymeric material via deformation of the polymeric material. In some such embodiments, the methods of deformation may include application of: tension, compression, shearing, stretching, grinding, and any combination thereof.
Furthermore,
Moreover,
In many embodiments, application of mechanical force, such as, for example, produced by ultrasonication of a solution comprising the mechanophore platform of the instant disclosure, induces mechanochemical activation of the mechanophore platform to reveal the unstable furan moiety, which, next, easily decomposes with the release of its covalently pre-installed cargo molecule. As one example of many embodiments,
Furthermore, the data in
The table provided in
Moreover,
In addition,
Accordingly, in many embodiments, the substituents on the furan moiety of the mechanophore platform affect the stability of the putative furfuryl cation intermediate formed during the furan moiety's decomposition and, consequently, influence the release of cargo from the mechanophore platforms of the instant disclosure. In many embodiments, the judicious design and selection of the furan moiety component in the synthesis and assembly of the mechanophore platform affords excellent control over the mechanophore platform's cargo release kinetics. In many embodiments, an electron-rich aryloxy group installed at 5-position of the furan moiety allows for efficient mechanophore platform synthesis and assembly, while also offering rate acceleration for the molecular cargo release (for both phenol and arylamine payloads), wherein such substituent simultaneously serves as the site of polymer attachment for efficient force transfer proximal to the furan-dienophile junction.
In many embodiments, the mechanophore platforms of the instant disclosure offer carrying capabilities for a wide scope of cargo molecules that they can release with controllable effectiveness upon mechanical activation. For example,
More specifically, for the cargo molecule release studies summarized in
Moreover, the data provided in
It should be noted that the percent release for each cargo molecule reported in
Furthermore, not to be bound by any theory, the reduced yield of the alkylamine cargo from the mechanophore platform of some embodiments, which plateaus at approximately 8%, can be attributed to a reaction between the released amine and the polymer-bound furfuryl cation intermediate, similar to the side reaction observed in the decomposition of model compound 21 at relatively high concentrations. Accordingly, the enhanced nucleophilicity of the alkylamine is anticipated to promote this side reaction pathway to an even greater extent than for aminocoumarin.
Moreover, although not to be bound by any particular theory, the relatively high yields of 41% observed for the release of both organic acid cargos (
Accordingly, in many embodiments, the mechanophore platform for mechanically triggered release of cargo molecules described herein is highly general and effective for a variety of molecular cargo as illustrated by
In many embodiments, a variety of the mechanophore platforms are assembled and covalently pre-loaded with functionally diverse molecular cargoes via highly modular synthetic routes allowing for unlimited diversification. In many such embodiments, the scope of the functionalities of the cargo molecules that exhibit release from the mechanophore platforms of embodiments and high reaction efficiencies, includes (but is not limited to): alkyl and aryl alcohols, alkyl and aryl amines, carboxylic and sulfonic acids. In addition, in many embodiments, the mechanophore platforms are actuated by ultrasound, which is very convenient and versatile means of mechanical actuation. As such, in some embodiments, the described herein highly modular, general, and efficient mechanophore platform for mechanically triggered release of a wide variety of functional molecules is a platform of choice for applications in catalysis, sensing, including stress sensing, drug delivery, depolymerization, and many other areas.
The following examples are put forth so as to provide those of ordinary skill in the art with a complete disclosure and description of how to make and use the present invention, and are not intended to limit the scope of what the inventors regard as their invention nor are they intended to represent that the experiments below are all or the only experiments performed. Efforts have been made to ensure accuracy with respect to numbers used (e.g. amounts, temperature, etc.) but some experimental errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, molecular weight is number average molecular weight, temperature is in degrees Celsius, and pressure is at or near atmospheric.
Reagents from commercial sources were used without further purification unless otherwise stated. Methyl acrylate was passed through a short plug of basic alumina to remove inhibitor immediately prior to use. Dry THF, diethyl ether, MeCN, and DMF were obtained from a Pure Process Technology solvent purification system. All reactions were performed under a N2 or argon atmosphere unless specified otherwise. Column chromatography was performed on a Biotage Isolera system using SiliCycle SiliaSep HP flash cartridges.
NMR spectra were recorded using a 400 MHz Bruker Avance III HD with Prodigy Cryoprobe, a 400 MHz Bruker Avance Neo, or Varian Inova 500 or 600 MHz spectrometers. All 1H NMR spectra are reported in δ units, parts per million (ppm), and were measured relative to the signals for residual chloroform (7.26 ppm), dichloromethane (5.32 ppm), methanol (3.31 ppm), toluene (2.08), acetone (2.05 ppm), or acetonitrile (1.94 ppm) in deuterated solvent. All 13C NMR spectra were measured in deuterated solvents and are reported in ppm relative to the signals for chloroform (77.16 ppm) or dichloromethane (54.00 ppm). Multiplicity and qualifier abbreviations are as follows: s=singlet, d=doublet, t=triplet, q=quartet, dd=doublet of doublets, ABq=AB quartet, m=multiplet, br=broad.
High resolution mass spectra (HRMS) were obtained from an Agilent 6200 series time-of-flight mass spectrometer equipped with an Agilent G1978A multimode source (Est). However, for some samples, high resolution mass spectra (HRMS) were analyzed by direct infusion electrospray ionization (ESI) in the positive ion mode using a Waters LCT Premier XE time-of-flight (TOF) mass spectrometer operated in the V mode. The instrument was externally calibrated with NaI clusters. Some samples were analyzed by Fast Atom Bombardment (FAB) using a JEOL JMS-60H Double-focusing high resolution magnetic sector mass spectrometer operated in the positive ion mode. In such instances, the instrument was calibrated with PEG clusters over the mass range of interest. One sample (217) was analyzed by GC-MS using an Agilent 6890N gas chromatograph interfaced to a JEOL double-focusing magnetic sector instrument using electron ionization (EI) in the positive ion mode. The instrument was calibrated with perfluorokerosene.
Analytical gel permeation chromatography (GPC) was performed using an Agilent 1260 series pump equipped with two Agilent PLgel MIXED-B columns (7.5×300 mm), an Agilent 1200 series diode array detector, a Wyatt 18-angle DAWN HELEOS light scattering detector, and an Optilab rEX differential refractive index detector. The mobile phase was THF at a flow rate of 1 mL/min. Molecular weights and molecular weight distributions were calculated by light scattering using a do/dc value of 0.062 mL/g (25° C.) for poly(methyl acrylate).
Photoluminescence spectra were recorded on a Shimadzu RF-6000 spectrofluorophotometer. For some samples, a quartz microcuvette (Starna Cells 18F-Q-10-GL14-C, 10×2 mm) was used. Excitation and emission slit widths used for aminocoumarin solutions were 5 nm and 3 nm, respectively.
High-Performance Liquid Chromatography (HPLC) was performed with an Agilent Eclipse Plus C18 Column (Product Number: 959961-902) equipped with a single-wavelength UV-vis detector.
Ultrasound experiments were performed inside of a sound abating enclosure using a 500 watt Vibra Cell 505 liquid processor (20 kHz) equipped with a 0.5-inch diameter solid probe (part #630-0217), sonochemical adapter (part #830-00014), and a Suslick reaction vessel made by the Caltech glass shop (analogous to vessel #830-00014 from Sonics and Materials).
LCMS measurements were performed with an Agilent 6140 Series Quadrupole LCMS Spectrometer System equipped with an Agilent Eclipse Plus C18 column using MeCN/water as the eluent.
A flame-dried round bottom flask equipped with a stir bar under nitrogen was charged with triphosgene (0.50 g, 1.7 mmol) and anhydrous THF (20 mL). The solution was cooled to 0° C. in an ice bath, followed by the dropwise addition of a solution of 7-hydroxy-4-methylcoumarin (0.88 g, 5.0 mol) and an-hydrous pyridine (0.40 mL, 5.0 mmol) dissolved in anhydrous THF (35 mL). A white precipitate formed quickly upon addition. The reaction was allowed to warm to rt and stirred for 18 h. The slurry was filtered through a silica plug under an inert atmosphere of nitrogen to remove the insoluble bis-coumarin carbonate byproduct. The crude mixture was dried, taken up into DCM (20 mL), and filtered twice under nitrogen to remove insoluble solids comprising mostly the hydroxycoumarin starting material. The filtrate was concentrated under reduced pressure to provide the title compound as a white powder (0.91 g, 76%), which was stored in a glovebox under nitrogen. 1H NMR (400 MHz, CDCl3) δ: 7.66 (d, J=8.7 Hz, 1H), 7.27-7.25 (m, 1H), 7.22 (d, J=2.4 Hz, 1H), 6.33 (q, J=1.2 Hz, 1H), 2.45 (d, J=1.3 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 160.1, 154.3, 153.2, 151.7, 149.2, 126.1, 119.2, 116.8, 115.5, 109.8, 18.9 ppm. HRMS (ESI, m/z): calcd. for [C11H8ClO4]+ (M+H)+, 239.0106; found, 239.0097.
A flame-dried round bottom flask was charged with furfuryl alcohol (14.2 mg, 0.145 mmol) and anhydrous DCM (5 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of anhydrous pyridine (12.3 μL, 0.152 mmol) and then a solution of coumarin chloroformate 8 (36.2 mg, 0.152 mmol) in anhydrous DCM (5 mL). The solution was allowed to warm to rt slowly, resulting in the formation of a white precipitate. The mixture was then diluted with DCM (20 mL) and washed with brine (2×20 mL). The combined organic phase was dried over Na2SO4, filtered, concentrated under reduced pressure, and purified by flash chromatography (5-35% EtOAc/hexanes) to yield the title compound as an off-white solid (43 mg, quant). Rf=0.64 (1:1 EtOAc:Hexanes). 1H NMR (500 MHz, CDCl3) δ: 7.61 (d, J=8.6 Hz, 1H), 7.48 (dd, J=1.9, 0.8 Hz, 1H), 7.23 (d, J=2.3 Hz, 1H), 7.17 (dd, J=8.7, 2.3 Hz, 1H), 6.54 (dd, J=3.2, 0.8 Hz, 1H), 6.41 (dd, J=3.3, 1.9 Hz, 1H), 6.28 (q, J=1.3 Hz, 1H), 5.26 (s, 2H), 2.44 (d, J=1.3 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 160.6, 154.3, 153.3, 152.8, 151.9, 148.0, 144.1, 125.6, 118.2, 117.5, 114.9, 112.2, 110.9, 110.1, 62.5, 18.9 ppm. HRMS (ESI, m/z): calcd. for [C16H13O6]+ (M+H)+, 301.0707; found, 301.0702.
A round bottom flask equipped with a stir bar was charged with NaBH4 (159 mg, 4.20 mmol) and methanol (10 mL). The solution was cooled to 0° C. in an ice bath followed by the slow addition of 5-hydroxymethyl-2-furaldehyde (478 mg, 3.79 mmol). The reaction mixture was allowed to slowly warm to rt and stirred for 3 h. The mixture was then washed with 10% NH4Cl (100 mL), extracted with EtOAc (2×100 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure to yield 2,5-bis(hydroxymethyl)furan as a white solid (410 mg), which was used in the next step without further purification.
A round bottom flask equipped with a stir bar was charged with 2,5-bis(hydroxymethyl)furan (410 mg, 3.2 mmol), triethylamine (0.49 mL, 3.5 mmol), and DCM (20 mL), followed by the dropwise addition of α-bromo-isobutyryl bromide (396 μL, 3.20 mmol). The reaction was allowed to warm to rt slowly and stirred for 3 h. The mixture was filtered through a plug of silica gel eluting with EtOAc:Hexanes (4:1), the filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography (25-50% EtOAc/Hexanes) to yield the title compound as a colorless oil (405 mg, 39% over two steps). Rf=0.26 (1:4 EtOAc:Hexanes). 1H NMR (400 MHz, CDCl3) δ: 6.40 (d, J=3.2 Hz, 1H), 6.27 (d, J=3.2 Hz, 1H), 5.13 (s, 2H), 4.60 (s, 2H), 1.92 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 171.5, 155.0, 148.9, 111.9, 108.9, 59.7, 57.7, 55.7, 30.8 ppm. HRMS (ESI, m/z): calcd. for [C10H17BrNO4]+ (M+H)+, 294.0335; found, 294.0327.
(5-(((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)methyl)furan-2-yl)methyl 2-bromo-2-methylpropanoate (S2). Furfuryl alcohol 9 (46.0 mg, 0.166 mmol) and pyridine (21.5 μL, 0.267 mmol) were combined with anhydrous DCM (2 mL) in a two-neck round bottom flask. The solution was cooled to 0° C. in an ice bath followed by the dropwise addition a solution of coumarin chloroformate 8 (60.0 mg, 0.251 mmol) dissolved in anhydrous DCM (4 mL). The reaction mixture was allowed to warm to rt and stirred for 2 h. The mixture was then concentrated under reduced pressure and the crude product was purified by column chromatography (10-60% EtOAc/hexanes) to yield the title compound as a colorless oil (76 mg, 96%). Rf=0.16 (1:4 EtOAc:Hexanes). 1H NMR (400 MHz, CDCl3) δ: 7.62 (d, J=8.7 Hz, 1H), 7.23 (d, J=2.3 Hz, 1H), 7.17 (dd, J=8.7, 2.4 Hz, 1H), 6.52 (d, J=3.3 Hz, 1H), 6.46 (d, J=3.2 Hz, 1H), 6.28 (q, J=1.3 Hz, 1H), 5.24 (s, 2H), 5.17 (s, 2H), 2.44 (d, J=1.3 Hz, 3H), 1.94 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ:171.4, 160.5, 154.3, 153.3, 152.7, 151.9, 150.4, 148.8, 125.7, 118.2, 117.5, 114.9, 113.2, 112.0, 110.1, 62.4, 59.6, 55.6, 30.8, 18.9 ppm. HRMS (ESI, m/z): calcd. for [C21H20BrO8]+ (M+H)+, 479.0336; found, 479.0337.
A 1 L round bottom flask equipped with a stir bar was charged with 5-(hydroxymethyl)furan-2-carbaldehyde (7.92 g, 62.8 mmol) and diethyl ether (300 mL). The solution was cooled to −30° C., followed by the slow addition of methylmagnesium bromide (3 M in diethyl ether, 42 mL, 130 mmol). The mixture was allowed to warm to rt and stirred for 12 h, after which the reaction was cooled to 0° C. and quenched with 10% NH4Cl (200 mL). The reaction mixture was extracted with EtOAc (3×100 mL) and the combined organic phase was dried over MgSO4, filtered, and concentrated under reduced pressure to provide the title compound as a viscous yellow oil (7.6 g, 85%). 1H NMR (400 MHz, CDCl3) δ: 6.23 (d, J=3.1 Hz, 1H), 6.18 (d, J=3.2 Hz, 1H), 4.87 (q, J=6.7 Hz, 1H), 4.59 (d, J=2.9 Hz, 2H), 1.97 (br s, 1H), 1.78 (br s, 1H), 1.54 (d, J=6.5 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 157.8, 153.5, 108.6, 106.1, 63.8, 57.7, 21.3 ppm. HRMS (ESI, m/z): calcd. for [C7H9O2]+ (M-OH)+, 125.0597; found, 125.0595.
(5-(1-hydroxyethyl)furan-2-yl)methyl 2-bromo-2-methylpropanoate (11). A 500 mL three neck flask was equipped with a stir bar was charged with 10 (2.74 g, 19.3 mmol), triethylamine (3.00 mL, 21.6 mmol), and DCM (150 mL). The mixture was cooled to 0° C. in an ice bath followed by the dropwise addition of a solution of α-bromo-isobutyryl bromide (2.60 mL, 21.0 mmol) dissolved in DCM (50 mL) over 2 h. The reaction mixture was stirred under nitrogen and allowed to warm to rt slowly. After 20 h, the reaction mixture was filtered through a plug of silica gel, washed with 1:1 EtOAc:Hexanes, concentrated, then purified by column chromatography (2-35% EtOAc/hexanes) to yield the title compound as a viscous colorless liquid (4.4 g, 77%). Rf=0.33 (1:4 EtOAc:Hexanes). 1H NMR (400 MHz, CDCl3) δ: 6.38 (d, J=3.2 Hz, 1H), 6.21 (d, J=3.4 Hz, 1H), 5.13 (s, 2H), 4.87 (q, J=6.6 Hz, 1H), 1.93 (s, 6H), 1.54 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 171.5, 158.7, 148.3, 111.7, 106.3, 63.8, 59.8, 55.8, 30.8, 21.4 ppm. HRMS (ESI, m/z): calcd. for [C11H14BrO3]+ (M-OH)+, 273.0121; found, 273.0119.
(5-(1-((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)ethyl)furan-2-yl)methyl 2-bromo-2-methylpropanoate (1). A two-neck round bottom flask equipped with a stir bar was charged with 11 (58.5 mg, 0.201 mmol), pyridine (19.0 μL, 0.236 mmol), and DCM (4 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of a solution of coumarin chloroformate 8 (53.5 mg, 0.224 mmol) dissolved in DCM (6 mL). The reaction was allowed to warm slowly to rt and stirred for 3 h. The reaction mixture was washed quickly with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure to yield a viscous oil. The crude oil was dispersed in DCM/hexanes (1:2, 3 mL), then filtered to remove insoluble byproducts consisting mostly of 7-hydroxy-4-methylcoumarin and the bis-coumarin carbonate. The filtrate was concentrated under reduced pressure to provide the title compound as a viscous colorless liquid (93 mg, 94%). Compound 1 is relatively stable in solvents such as DCM, chloroform, and hexanes, but decomposes quickly in acidic and protic solvents. 1H NMR (400 MHz, CDCl3) δ: 7.61 (d, J=8.7 Hz, 1H), 7.23 (d, J=2.3 Hz, 1H), 7.17 (dd, J=8.7, 2.4 Hz, 1H), 6.43 (s, 2H), 6.28 (d, J=1.3 Hz, 1H), 5.88 (q, J=6.7 Hz, 1H), 5.17 (ABq, ΔνAB=5.8 Hz, JAB=13.6 Hz, 2H), 2.43 (d, J=1.3 Hz, 3H), 1.94 (s, 6H), 1.74 (d, J=6.8 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 171.4, 160.6, 154.3, 153.3, 152.6, 152.3, 152.0, 149.6, 125.6, 118.1, 117.5, 114.8, 111.7, 110.2, 110.1, 70.7, 59.6, 55.7, 30.8, 18.9, 18.1 ppm. HRMS (ESI, m/z): calcd. for [C22H25BrNO8]+ (M+NH4)+, 501.0758; found, 501.0750.
Compound 1 (80.2 mg, 0.163 mmol) was dissolved in methanol (1 mL) in a 2 ml vial and stirred at rt. After 16 h, the reaction mixture was concentrated under reduced pressure and the crude product was purified by flash chromatography (1-25% EtOAc/hexanes) to provide the title compound as a colorless viscous oil (43 mg, 87%). Rf=0.31 (1:19 EtOAc:Hexanes). 1H NMR (500 MHz, CDCl3) δ: 6.38 (d, J=3.2 Hz, 1H), 6.23 (d, J=3.2 Hz, 1H), 5.13 (ABq, ΔνAB=7.5 Hz, JAB=13.0 Hz, 2H), 4.34 (q, J=6.6 Hz, 1H), 3.28 (d, J=1.0 Hz, 3H), 1.92 (d, J=0.8 Hz, 6H), 1.49 (dd, J=6.6, 0.9 Hz, 3H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ: 171.4, 156.5, 148.4, 111.5, 108.0, 72.1, 59.8, 56.3, 55.7, 30.8, 30.8, 19.5 ppm. HRMS (ESI, m/z): calcd. for [C12H21BrNO4]+ (M+NH4)+, 322.0648; found, 322.0654.
Compound 11 (4.15 g, 14.3 mmol) was combined with N-(2-hydroxyethyl)maleimide1 (3.51 g, 24.9 mmol) and chloroform (4 mL) in a 20 mL vial and stirred at 55° C. for 14 h. The crude reaction mixture was separated by column chromatography (2-4% methanol/DCM) and a single diastereomer of the title compound was isolated as a white solid (2.2 g, 36%). The absolute configuration of compound 12 was confirmed by single crystal X-ray diffraction. Rf=0.28 (1:24 methanol:DCM). 1H NMR (400 MHz, CDCl3) δ: 6.43 (d, J=5.8 Hz, 1H), 6.38 (d, J=5.8 Hz, 1H), 4.81 (ABq, ΔνAB=78 Hz, JAB=12.8 Hz, 2H), 4.34 (q, J=7.1 Hz, 1H), 3.73-3.50 (m, 6H), 1.95 (s, 6H), 1.43 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 175.5, 175.0, 171.2, 135.7, 135.0, 95.0, 89.4, 66.7, 63.2, 60.6, 55.5, 49.5, 47.7, 41.5, 30.8, 30.8, 18.7 ppm. HRMS (ESI, m/z): calcd. for [C17H22BrNO7Na]+ (M+Na)+, 454.0472; found, 454.0470.
2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-hydroxyethyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate ((±)-4). A three-neck round bottom flask equipped with a stir bar was charged with 12 (1.08 g, 2.50 mmol), triethylamine (0.39 mL, 2.8 mmol), and DCM (50 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of α-bromo-isobutyryl bromide (0.33 mL, 2.7 mmol). The solution was allowed to warm to rt slowly and stirred for an additional 16 h. The reaction mixture was washed with NH4Cl (100 mL) and brine (100 mL), dried over Na2SO4, filtered, and the organic fraction was concentrated under reduced pressure. The crude product was purified by column chromatography (35-55% EtOAc/hexanes) to provide the title compound as a colorless, sticky oil (1.1 g, 74%). Rf=0.29 (1:1 EtOAc/hexanes). 1H NMR (400 MHz, CDCl3) δ: 6.46 (d, J=5.7 Hz, 1H), 6.41 (d, J=5.8 Hz, 1H), 4.80 (ABq, ΔνAB=84 Hz, JAB=12.8 Hz, 2H), 4.33 (q, J=6.6 Hz, 1H), 4.22 (dd, J=5.7, 4.7 Hz, 2H), 3.73-3.62 (m, 3H), 3.58 (d, J=7.7 Hz, 1H), 1.96 (s, 5H), 1.90 (s, 6H), 1.44 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 174.5, 174.0, 171.5, 171.2, 135.7, 135.1, 95.0, 89.4, 66.8, 63.2, 62.6, 55.6, 55.5, 49.6, 47.8, 37.6, 30.81, 30.80, 30.79, 30.77, 18.7 ppm. HRMS (ESI, m/z): calcd. for [C21H31Br2N2O8]+ (M+NH4)+, 599.0421; found, 599.0420.
2-(−4-(((2-bromo-2-methylpropanoyl)oxy)methyl)-7-(−1-hydroxyethyl)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-2-yl)ethyl pivalate ((±)-5). A two-neck round bottom flask equipped with a stir bar was charged with 12 (410 mg, 0.95 mmol), triethylamine (0.21 mL, 1.5 mmol), and DCM (15 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of pivaloyl chloride (0.18 mL, 1.5 mmol). The solution was allowed to warm to rt slowly and stirred for an addition-al 23 h. The reaction mixture was filtered through a plug of silica gel and the filtrate was concentrated under reduced pressure. The crude product was purified by column chromatography (30-55% EtOAc/hexanes) to provide the title compound as a colorless viscous oil (315 mg, 64%). Rf=0.56 (1:1 EtOAc:Hexanes). 1H NMR (500 MHz, CDCl3) δ: 6.42 (d, J=5.7 Hz, 1H), 6.37 (d, J=5.8 Hz, 1H), 4.80 (ABq, ΔνAB=106 Hz, JAB=12.5 Hz, 2H), 4.33 (q, J=6.6 Hz, 1H), 4.11 (t, J=5.3 Hz, 2H), 3.66 (d, J=7.7 Hz, 1H), 3.63-3.59 (m, 2H), 3.57 (d, J=7.8 Hz, 1H), 1.96 (s, 6H), 1.44 (d, J=6.6 Hz, 3H), 1.17 (s, 8H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ: 178.3, 174.5, 174.0, 171.2, 135.7, 135.0, 94.9, 89.3, 66.8, 63.2, 61.0, 55.5, 49.5, 47.7, 38.8, 38.0, 30.80, 30.75, 27.3, 18.6 ppm. HRMS (ESI, m/z): calcd. for [C22H31BrN2O8]+ (M+H)+, 516.1228; found, 516.1228.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(−1-((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)ethyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate ((±)6). A two-neck round bottom flask equipped with a stir bar was charged with 4 (68.8 mg, 0.118 mmol), pyridine (30.0 μL, 0.372 mmol), and DCM (25 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of a solution of coumarin chloroformate 8 (81.0 mg, 0.339 mmol) dissolved in DCM (5 mL). The reaction was allowed to warm slowly to rt and stirred for 20 h. The reaction mixture was washed with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude produce was purified by column chromatography (35-55% EtOAc/hexanes) to provide the title compound as a white foaming solid (76 mg, 82%). Rf=0.35 (1:1 EtOAc:Hexanes). 1H NMR (400 MHz, CDCl3) δ: 7.62 (d, J=8.7 Hz, 1H), 7.26 (s, 1H), 7.21 (dd, J=8.7, 2.3 Hz, 1H), δ 6.53-6.46 (m, 2H), 6.28 (q, J=1.3 Hz, 1H), 5.46 (q, J=6.6 Hz, 1H), 4.82 (ABq, ΔνAB=95 Hz, JAB=12.8 Hz, 2H), 4.24 (t, J=5.1 Hz, 2H), 3.77-3.56 (m, 4H), 2.44 (d, J=1.3 Hz, 3H), 1.95 (d, J=1.9 Hz, 6H), 1.91 (s, 6H), 1.64 (d, J=6.7 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 173.7, 173.5, 171.5, 171.2, 160.5, 154.3, 153.3, 152.2, 151.9, 135.6, 135.2, 125.6, 118.2, 117.5, 114.9, 110.1, 92.6, 89.5, 73.9, 63.1, 62.5, 55.7, 55.5, 49.4, 48.4, 37.8, 30.80, 30.78, 18.9, 16.0 ppm. HRMS (ESI, m/z): calcd. for [C32H37Br2N2O12]+ (M+NH4)+, 801.0687; found, 801.0684.
2-(−4-(((2-bromo-2-methylpropanoyl)oxy)methyl)-7-(−1-((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)ethyl)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-2-yl)ethyl pivalate ((±)-7). A two-neck round bottom flask equipped with a stir bar was charged with 5 (74.6 mg, 0.144 mmol), pyridine (23.4 μL, 0.291 mmol), and DCM (25 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of a solution of coumarin chloroformate 8 (69.0 mg, 0.289 mmol) dissolved in DCM (10 mL). The reaction was allowed to warm slowly to rt and stirred for 16 h. The reaction mixture was washed with 10% NH4Cl, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude produce was purified by column chromatography (35-60% EtOAc/hexanes) to provide the title compound as a white foaming solid (103 mg, quant). Rf=0.56 (1:1 EtOAc:Hexanes). 1H NMR (500 MHz, CDCl3) δ: 7.62 (d, J=8.7 Hz, 1H), 7.27-7.25 (m, 1H), 7.21 (dd, J=8.7, 2.4 Hz, 1H), 6.47-6.42 (m, 2H), 6.29 (q, J=1.3 Hz, 1H), 5.46 (q, J=6.6 Hz, 1H), 4.82 (ABq, ΔνAB=120 Hz, JAB=12.5 Hz, 2H), 4.13 (t, J=5.2 Hz, 2H), 3.76-3.55 (m, 4H), 2.45 (d, J=1.3 Hz, 3H), 1.96 (d, J=2.7 Hz, 6H), 1.65 (d, J=6.6 Hz, 3H), 1.18 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 178.4, 173.7, 173.5, 171.2, 160.5, 154.3, 153.3, 152.2, 151.9, 135.5, 135.1, 125.6, 118.2, 117.5, 114.9, 110.0, 92.6, 89.5, 73.9, 63.2, 61.0, 55.5, 49.3, 48.3, 38.9, 38.2, 30.79, 30.76, 27.3, 18.9, 16.0 ppm. HRMS (ESI, m/z): calcd. for [C33H37BrNO12]+ (M+H)+, 718.1494; found, 718.1500.
Mechanophore platform PMA-1. A 10 mL Schlenk flask equipped with a stir bar was charged with bis-initiator 6 (7.2 mg, 9.2 μmol), DMSO (1.2 mL), methyl acrylate (1.2 mL, 13 mmol), and Me6TREN (4.6 mg, 20 μmol). The flask was sealed, the solution was de-oxygenated with three freeze-pump-thaw cycles, and then backfilled with nitrogen. The flask was opened briefly under a flow of N2, and freshly cut copper wire (1.0 cm length, 20 gauge) was added on top of the frozen mixture. The flask was resealed, evacuated for an additional 15 min, warmed to rt, and then backfilled with nitrogen. After stirring at rt for 90 min, the flask was opened to air and the solution was diluted with DCM. The polymer solution was precipitated into cold methanol (2×) and the isolated material was dried under vacuum to yield 60 mg of PMA-1 (52%). Mn=100 kg/mol, Ð=1.06.
PMA-control. A 10 mL Schlenk flask equipped with a stir bar was charged with initiator 7 (8.5 mg, 11.8 μmol), DMSO (1.6 mL), methyl acrylate (1.6 mL, 18 mmol), and Me6TREN (5.1 mg, 22 μmol). The flask was sealed, the solution was deoxygenated with three freeze-pump-thaw cycles, and then backfilled with nitrogen. The flask was opened briefly under a flow of N2, and freshly cut copper wire (1.1 cm length, 20 gauge) was added on top of the frozen mixture. The flask was resealed, evacuated for an additional 15 min, warmed to rt, and then backfilled with nitrogen. After stirring at rt for 2 h, the flask was opened to air and the solution was diluted with DCM. The polymer solution was precipitated into cold methanol (2×) and the isolated material was dried under vacuum to yield 82 mg of PMA-control (54%). Mn=86 kg/mol, Ð=1.14.
A round bottom flask equipped with a stir bar was charged with phenol (16.1 g, 0.171 mol), cesium carbonate (55.7 g, 0.171 mol) and DMF (500 mL). The solution was heated to 80° C. until cesium carbonate had dissolved. The mixture was then cooled to 60° C. before adding 3-bromo-2-furfural 1 (6.30 g, 0.0360 mol), and vigorously stirred for 1 day. The reaction mixture was then cooled to room temperature before pouring into a sat. Na2CO3 solution (1 L), extracted with Et2O (4×300 mL), and washed with copious sat. Na2CO3 and brine. The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (5-20% EtOAc/hexanes) to yield the title compound as a light-yellow solid (2.90 g, 43%). 1H NMR (500 MHz, CDCl3) δ 9.67 (s, 1H), 7.52 (d, J=2.1, 1H), 7.43-7.37 (m, 2H), 7.25-7.20 (m, 1H), 7.19-7.13 (m, 2H), 6.22 (d, J=2.1 Hz, 1H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 174.9, 156.1, 148.0, 139.5, 130.3, 125.4, 119.0, 105.4 ppm. HRMS (ESI, m/z): calcd. for [C11H9O3]+ (M+H)+, 189.0546; found, 189.0568.
Tert-butyldimethyl(1-(3-phenoxyfuran-2-yl)ethoxy)silane (26). A flame-dried round bottom flask was charged with 25 (1.50 g, 7.98 mmol) and anhydrous Et2O (50 mL). The solution was cooled to −30° C. in an acetonitrile/dry ice bath followed by the dropwise addition of MeMgBr (3 M in Et2O, 4.00 mL, 12.0 mmol). The solution was allowed to warm to room temperature and stirred for 1 h before being quenched with 10% NH4Cl (50 mL) and extracted with Et2O (2×50 mL). The combined organic phase was dried over Na2SO4, filtered, concentrated under reduced pressure to yield 1-(3-phenoxyfuran-2-yl)ethan-1-ol as a colorless oil, which was used in the next step without further purification.
A round bottom flask equipped with a stir bar was charged with 1-(3-phenoxyfuran-2-yl)ethan-1-ol (1.60 g, 7.84 mmol), imidazole (1.60 g, 23.5 mmol), and DCM (15 mL), followed by addition of tert-butylchlorodimethylsilane (2.40 g, 16.0 mmol). The reaction was allowed to stir at room temperature overnight before filtering the mixture through a cotton pad. The filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography (0-15% EtOAc/hexanes) to yield the title compound as a light yellow oil (2.49 g, 98% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.33-7.27 (m, 3H), 7.06-7.01 (m, 1H), 7.00-6.95 (m, 2H), 6.19 (d, J=2.1 Hz, 1H), 4.93 (q, J=6.6 Hz, 1H), 1.47 (d, J=6.6 Hz, 3H), 0.85 (s, 9H), 0.04 (s, 3H), −0.05 (s, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 158.4, 145.2, 140.7, 137.7, 129.7, 122.5, 116.2, 106.3, 61.6, 25.9, 25.8, 22.2, 18.3, −4.9, −5.0 ppm. HRMS (ESI, m/z): calcd. for [C12H11O2]+ (M-OTBS)+, 187.0754; found, 187.0732.
5-(1-hydroxyethyl)-4-phenoxyfuran-2-carbaldehyde (27). A flame-dried round bottom flask equipped with a stir bar was charged with diisopropylamine (0.80 mL, 5.7 mmol) and THF (70 mL). The solution was cooled to −78° C. in an acetone/dry ice bath before adding n-butyllithium (2.5 M in hexanes, 2.30 mL, 5.75 mmol) dropwise. After stirring the mixture for 5 min, a solution of 26 (1.06 g, 5.02 mmol) in THF (10 ml) was added to the mixture dropwise at −78° C. The mixture was kept at −78° C. for 30 mins before adding DMF (0.52 mL, 6.7 mmol) dropwise. The mixture was then allowed to slowly warm up to room temperature for ˜1 h before 10% NH4Cl (100 mL) was added slowly to the mixture to quench the reaction. The mixture was then extracted with Et2O (2×100 mL), and the organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The crude mixture was purified by column chromatography (0-20% EtOAc/hexanes) to yield the crude product of 5-(1-((tert-butyldimethylsilyl)oxy)ethyl)-4-phenoxyfuran-2-carbaldehyde as a colorless oil. Approximately 10% of the crude product was identified to be the regioisomer resulting from formylation at the 4-position of the furan. The crude product was used in the next step without further purification.
The crude product from above was dissolved in THF (25 mL) and cooled to 0° C. before adding TBAF (1 M in THF, 3.8 mL, 3.8 mmol) dropwise. The mixture was allowed to slowly warm up to room temperature and stirred for 1 h. The reaction mixture was then diluted with Et2O (25 mL) washed with NH4Cl (25 mL) and brine (25 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (25-50% EtOAc/hexanes) to yield compound 27 as a yellow waxy solid (602 mg, 52% over two steps). 1H NMR (400 MHz, CDCl3) δ 9.57 (s, 1H), 7.35 (dd, J=8.7, 7.4 Hz, 2H), 7.19-7.08 (m, 1H), 7.05-6.96 (m, 3H), 5.04 (q, J=6.7 Hz, 1H), 1.62 (d, J=6.7 Hz, 3H). 13C{1H} NMR (100 MHz, CDCl3) δ 178.0, 157.4, 150.9, 149.4, 140.9, 130.1, 123.8, 116.8, 115.2, 61.9, 20.9 ppm. HRMS (ESI, m/z): calcd. for [C13H13O4]+ (M+H)+, 233.0808; found, 233.0808.
2-(−4-(1-hydroxyethyl)-7-(hydroxymethyl)-1,3-dioxo-5-phenoxy-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-2-yl)ethyl 2-bromo-2-methylpropanoate ((±)-28). A round bottom flask equipped with a stir bar was charged with 27 (350.0 mg, 1.509 mmol), THF (3 mL) and MeOH (10 mL). The solution was cooled to 0° C. in an ice bath before slowly adding NaBH4 (82.0 mg, 2.17 mmol). The mixture was kept at 0° C. for 1 h before adding 10% NH4Cl (10 mL), extracted with EtOAc (2×10 mL), and washed with brine (10 mL). The organic layer was dried over Na2SO4, and filtered. Maleimide 214 (for example of synthesis, see Deng, G.; Chen, Y. A Novel Way To Synthesize Star Polymers in One Pot by ATRP of N-[2-(2-Bromoisobutyryloxy)ethyl]maleimide and Styrene. Macromolecules 2004, 37, 18-26, the disclosure of which is incorporated herein by reference) (527 mg, 2.77 mmol) was then added and the solution was concentrated under reduced pressure until about 2 mL viscous solution remained. The solution was then stirred at room temperature for 4 h, and the crude mixture was purified by column chromatography (72-90% EtOAc/Hexanes). A single diastereomer of the title compound was isolated as a colorless oil (285 mg, 36% yield). 1H NMR (400 MHz, CDCl3) δ 7.38-7.30 (m, 2H), 7.22-7.16 (m, 1H), 7.00-6.94 (m, 2H), 4.96 (s, 1H), 4.59 (s, 1H), 4.32-3.97 (m, 5H), 3.78-3.53 (m, 3H), 2.04 (m, 2H), 1.87 (d, J=0.8 Hz, 6H), 1.54 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 175.1, 174.1, 171.5, 163.5, 154.8, 130.2, 126.1, 119.9, 100.9, 92.3, 90.4, 65.0, 62.5, 62.4, 55.7, 50.9, 48.0, 37.5, 30.7, 30.7, 19.0 ppm. HRMS (ESI, m/z): calcd. for [C23H27BrNO8]+ (M+H)+, 524.0915; found, 524.0928.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-hydroxyethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate ((±)-29). A flame-dried round bottom flask equipped with a stir bar was charged with (±)-28 (263 mg, 0.502 mmol), Et3N (84 μL, 0.60 mmol) and DCM (15 mL). The solution was cooled to 0° C. before adding α-bromo-isobutyryl bromide (68 μL, 0.55 mmol) dropwise. The reaction was then allowed to warm to room temperature and stirred overnight until the reaction had completed, as determined by TLC. The reaction mixture was then washed with NH4Cl (30 mL) and brine (30 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (35-50% EtOAc/Hexanes) to yield the title compound as a colorless oil (270 mg, 80% yield). 1H NMR (400 MHz, CDCl3) δ 7.39-7.30 (m, 2H), 7.23-7.15 (m, 1H), 7.01-6.91 (m, 2H), 4.95 (s, 1H), 4.68 (ABq, ΔνAB=126.4 Hz, JAB=58.0 Hz, 2H), 4.63-4.57 (m, 1H), 4.33-4.11 (m, 2H), 4.00 (d, J=7.8 Hz, 1H), 3.79-3.52 (m, 3H), 1.96 (m, 7H), 1.86 (s, 6H), 1.52 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 174.1, 173.7, 171.4, 171.0, 163.5, 154.6, 130.1, 126.0, 119.7, 100.8, 92.1, 88.2, 64.8, 63.5, 62.3, 55.5, 55.5, 51.1, 47.5, 37.3, 30.7, 30.6, 18.7 ppm. HRMS (ESI, m/z): calcd. for [C27H32Br2NO9]+ (M+H)+, 672.0438; found, 672.0462.
A flame-dried round bottom flask equipped with a stir bar was charged with (±)-28 (137 mg, 0.261 mmol), Et3N (52.3 μL, 0.376 mmol), DMAP (41.7 mg, 0.342 mmol) and DCM (5 mL). The solution was cooled to 0° C. before adding pivaloyl chloride (46.3 μL, 0.376 mmol) dropwise. The reaction was then allowed to warm to room temperature and stirred overnight until the reaction completed, as determined by TLC. The reaction mixture was then diluted with DCM (20 mL), washed with NH4Cl (30 mL) and brine (30 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (10-50% EtOAc:Hexanes) to yield the title compound as a white waxy solid (90 mg, 57% yield). 1H NMR (400 MHz, CDCl3) δ 7.40-7.29 (m, 2H), 7.24-7.15 (m, 1H), 6.99-6.90 (m, 2H), 4.90 (s, 1H), 4.57 (ABq, ΔνAB=113.0 Hz, JAB=12.7 Hz, 2H), 4.55 (dt, J=7.6, 6.4 Hz, 1H), 4.33-4.12 (m, 2H), 3.99 (d, J=7.8 Hz, 1H), 3.79-3.51 (m, 3H), 1.96 (d, J=7.9 Hz, 1H), 1.87 (d, J=1.3 Hz, 6H), 1.52 (d, J=6.6 Hz, 3H), 1.22 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 177.9, 174.3, 173.9, 171.5, 163.5, 154.8, 130.2, 126.1, 119.8, 101.1, 92.1, 88.6, 64.9, 62.5, 62.3, 55.7, 51.2, 47.7, 39.1, 37.5, 30.7, 27.3, 18.8 ppm. HRMS (ESI, m/z): calcd. for [C24H35BrNO9]+ (M+H)+, 608.1490; found, 608.1479.
A flame-dried round bottom flask equipped with a stir bar under nitrogen was charged with triphosgene (0.59 g, 2.0 mmol) and anhydrous DCM (30 mL). The solution was cooled to 0° C. in an ice bath, followed by the addition of 23 (0.97 g, 5.5 mmol). Triethylamine (1.5 mL, 11 mmol) was dropwise added into the reaction. The reaction was allowed to warm to room temperature and stirred for 18 h. Hexane (30 mL) and DCM (60 mL) were added into the reaction mixture and the suspension was filtered to remove the pale yellow precipitate. The filtrate was washed with HCl (50 mL, 1 M), dried over MgSO4, and filtered. The solid was discarded and the filtrate was concentrated under reduced pressure. The solid was dispersed in hexane (10 mL) and DCM (20 mL), filtered, and the filtrate was concentrated. The solid was dissolved in DCM (5 mL), and the solution was precipitated into hexane (30 mL). The fluffy white solid was collected by filtration and dried under reduced pressure to provide the title compound (0.85 g, 77%). 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J=8.0, 0.8 Hz, 1H), 7.09-6.99 (m, 2H), 6.26 (q, J=1.3 Hz, 1H), 2.42 (d, J=1.3 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 160.4, 154.4, 151.8, 136.9, 125.8, 125.7, 121.3, 118.0, 114.8, 113.1, 18.8 ppm. HRMS (ESI, m/z): calcd. for [C11H8NO3]+ (M+H)+, 202.0499; found, 202.0495.
A two-neck round bottom flask equipped with a stir bar was charged with (±)-29 (20.4 mg, 0.0303 mmol), dry pyridine (3.2 μL, 0.040 mmol), and DCM (0.5 mL). The solution was cooled to 0° C. in an ice bath followed by the dropwise addition of a solution of coumarin chloroformate (9.4 mg, 0.039 mmol) in 0.5 mL DCM. The reaction was allowed to warm slowly to room temperature and stirred for 20 h. The reaction mixture was washed with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (35-55% EtOAc:Hexanes) to afford the title compound as a white foamy solid (21.7 mg, 82%). 1H NMR (400 MHz, CDCl3) δ 7.63 (d, J=8.7 Hz, 1H), 7.39-7.32 (m, 2H), 7.28 (d, J=2.3 Hz, 1H), 7.26-7.17 (m, 2H), 6.29 (q, J=1.3 Hz, 1H), 5.66 (q, J=6.5 Hz, 1H), 5.04 (s, 1H), 4.71 (ABq, ΔνAB=107.6 Hz, JAB=12.6 Hz, 2H), 4.34-4.12 (m, 2H), 3.89 (d, J=7.9 Hz, 1H), 3.77-3.53 (m, 3H), 2.45 (d, J=1.3 Hz, 3H), 1.96 (d, J=2.2 Hz, 6H), 1.86 (d, J=1.4 Hz, 6H), 1.72 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.7, 173.0, 171.5, 171.1, 162.5, 160.5, 154.6, 154.3, 153.3, 152.1, 151.9, 130.3, 126.3, 125.7, 119.7, 118.2, 117.5, 114.9, 110.0, 101.2, 90.3, 88.5, 72.5, 63.6, 62.4, 60.5, 55.7, 55.6, 51.4, 48.1, 37.6, 30.8, 30.7, 30.7, 21.2, 18.9, 15.8, 14.3 ppm. HRMS (ESI, m/z): calcd. for [C38H37Br2NO13]+ (M)+, 873.0626; found, 873.0610.
2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-10(O-control)). The title compound was prepared following a similar procedure as that for compound (±)-10(O), with compound (±)-29-control (35.0 mg, 0.0576 mmol), coumarin chloroformate (54.8 mg, 0.230 mmol), dry pyridine (18.6 μL, 0.230 mmol), and DCM (0.5 mL). The crude product was purified by column chromatography (35-55% EtOAc/Hexanes) to afford the title compound as a white foamy solid (43.4 mg, 86%). 1H NMR (400 MHz, CDCl3) δ 7.63 (d, J=8.7 Hz, 1H), 7.41-7.31 (m, 2H), 7.29-7.27 (m, 1H), 7.25-7.18 (m, 2H), 7.01-6.92 (m, 2H), 6.29 (d, J=1.3 Hz, 1H), 5.65 (q, J=6.5 Hz, 1H), 4.99 (s, 1H), 4.60 (ABq, ΔνAB=119.4 Hz, JAB=12.0 Hz, 2H), 4.34-4.24 (m, 1H), 4.23-4.11 (m, 1H), 3.89 (d, J=7.8 Hz, 1H), 3.71 (ddd, J=14.2, 6.7, 4.0 Hz, 1H), 3.66-3.57 (m, 2H), 2.45 (d, J=1.3 Hz, 3H), 1.87 (s, 6H), 1.71 (d, J=6.6 Hz, 3H), 1.23 (s, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ 177.9, 173.8, 173.1, 171.6, 162.5, 160.5, 154.7, 154.3, 153.3, 152.2, 151.9, 130.3, 126.3, 125.7, 119.7, 118.2, 117.5, 114.9, 110.0, 101.4, 90.2, 88.8, 72.5, 62.4, 62.3, 55.7, 51.4, 48.1, 39.1, 37.6, 30.7, 30.7, 27.3, 18.9, 15.7 ppm. HRMS (ESI, m/z): calcd. for [C39H41BrNO13]+ (M+H)+, 810.1397; found, 810.1368.
A two-neck round bottom flask equipped with a stir bar was charged with (±)-29 (31.5 mg, 0.0468 mmol), coumNCO (36.0 mg, 0.179 mmol) and DCM (3 mL). The mixture was cooled to 0° C. in ice bath before adding DMAP (21.9 mg, 0.179 mmol). The reaction was allowed to warm to room temperature and its progress was monitored by 1H NMR spectroscopy until completion (˜2 h). The mixture was then washed with brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude produce was purified by column chromatography (35-55% EtOAc/Hexanes) to provide the title compound as a white foamy solid (38.5 mg, 94%). 1H NMR (400 MHz, CDCl3) δ 7.57-7.50 (m, 1H), 7.48-7.41 (m, 2H), 7.39-7.30 (m, 2H), 7.25-7.17 (m, 2H), 7.01-6.92 (m, 2H), 6.20 (q, J=1.2 Hz, 1H), 5.77 (q, J=6.5 Hz, 1H), 5.02 (s, 1H), 4.70 (ABq, ΔνAB=99.8 Hz, JAB=12.6 Hz, 2H), 4.33-4.10 (m, 2H), 3.82 (d, J=7.9 Hz, 1H), 3.76-3.53 (m, 3H), 2.41 (d, J=1.3 Hz, 3H), 1.96 (s, 6H), 1.85 (s, 6H), 1.60 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.8, 173.0, 171.6, 171.1, 162.9, 161.1, 154.7, 154.6, 152.3, 151.9, 141.3, 130.3, 126.2, 125.6, 119.6, 115.8, 114.5, 113.5, 106.1, 100.8, 90.5, 88.5, 63.6, 62.4, 55.7, 55.6, 51.3, 48.1, 37.6, 30.8, 30.7, 30.7, 18.7, 16.1 ppm. HRMS (ESI, m/z): calcd. for [C38H38Br2N2O12]+ (M)+, 872.0786; found, 872.0792.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-(((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-10(N-control)). The title compound was prepared following a similar procedure as that for compound (±)-10(N), with compound (±)-29-control (24.4 mg, 0.0401 mmol), coumNCO (16.0 mg, 0.0796 mmol), DMAP (9.8 mg, 0.080 mmol), and DCM (0.5 mL). The crude product was purified by column chromatography (35-55% EtOAc/Hexanes) to afford the title compound as a white foamy solid (25.1 mg, 78%). 1H NMR (400 MHz, CDCl3) δ 7.50-7.37 (m, 4H), 7.31-7.22 (m, 2H), 7.17-7.08 (m, 1H), 6.93-6.84 (m, 2H), 6.12 (s, 1H), 5.70 (q, J=6.5 Hz, 1H), 4.91 (s, 1H), 4.52 (ABq, ΔνAB=102.8 Hz, JAB=16.0 Hz, 2H), 4.25-4.15 (m, 1H), 4.14-4.02 (m, 1H), 3.77 (d, J=7.8 Hz, 1H), 3.68-3.44 (m, 3H), 2.34 (d, J=1.3 Hz, 3H), 1.78 (d, J=1.3 Hz, 7H), 1.53 (d, J=6.5 Hz, 3H), 1.15 (d, J=1.5 Hz, 9H). 13C{1H} NMR (100 MHz, CDCl3) δ 177.9, 173.8, 173.1, 171.5, 162.8, 161.2, 154.7, 154.5, 152.4, 152.0, 141.5, 130.2, 130.1, 126.1, 125.5, 119.6, 115.7, 114.6, 113.3, 106.4, 101.0, 90.4, 88.8, 68.1, 62.4, 62.4, 55.8, 51.3, 48.1, 39.0, 37.6, 30.7, 30.7, 27.3, 18.7, 16.1.ppm. HRMS (ESI, m/z): calcd. for [C39H42BrN2O12]+ (M+H)+, 809.1916; found, 809.1948.
A round bottom flask equipped with a stir bar was charged with MeOH (10 mL) and cooled to 0° C. in an ice bath before adding NaBH4 (111 mg, 2.92 mmol), followed by the slow addition of 25 (303 mg, 1.61 mmol). The mixture was kept at 0° C. for 1 h before adding 10% NH4Cl (50 mL), and extracted with EtOAc (2×50 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure to yield (3-phenoxyfuran-2-yl)methanol as a light yellow oil (300 mg, 98%) which was used in the next step without further purification.
A round bottom flask equipped with a stir bar was charged with (3-phenoxyfuran-2-yl)methanol (300 mg, 1.58 mmol), imidazole (191 mg, 2.81 mmol), and DCM (10 mL), followed by addition of tert-butylchlorodimethylsilane (265 mg, 1.76 mmol). The reaction was allowed to stir at room temperature overnight before filtering the mixture through a cotton pad. The filtrate was concentrated under reduced pressure, and the crude product was purified by column chromatography (0-20% EtOAc/Hexanes) to yield the title compound as a light-yellow oil (447 mg, 92% over two steps). 1H NMR (400 MHz, CDCl3) δ 7.34-7.26 (m, 3H), 7.08-6.97 (m, 3H), 6.22 (d, J=2.1 Hz, 1H), 4.61 (s, 2H), 0.87 (s, 9H), 0.04 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 158.3, 142.4, 141.4, 139.8, 129.7, 122.6, 116.4, 106.3, 54.7, 26.0, 18.6, −5.2 ppm. HRMS (EI, m/z): calcd. for [C17H23O3Si]+ (M−H)+, 303.1411; found, 303.1407.
A flame-dried round bottom flask equipped with a stir bar was charged with diisopropylamine (0.30 mL, 2.1 mmol) and THF (10 mL). The solution was cooled to −78° C. in an acetone/dry ice bath before adding n-butyllithium (0.70 mL, 1.8 mmol, 2.5 M in hexanes) dropwise. After stirring the mixture for 5 mins, a solution of 217 (354 mg, 1.16 mmol) in THF (10 ml) was added dropwise at −78° C. The mixture was kept at −78° C. for 30 mins before adding DMF (1.0 mL, 13 mmol) dropwise. The mixture was then allowed to slowly warm up to room temperature over an hour before 10% NH4Cl (50 mL) was added slowly to quench the reaction. The mixture was extracted with Et2O (2×50 mL), and the organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (0-10% EtOAc/Hexanes) to yield the title compound as a light-yellow oil (351 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 9.59 (s, 1H), 7.39-7.29 (m, 2H), 7.15-7.06 (m, 1H), 7.05-6.97 (m, 3H), 4.70 (s, 2H), 0.88 (s, 9H), 0.07 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 178.2, 157.3, 149.8, 148.3, 142.0, 129.8, 123.5, 116.7, 114.2, 54.9, 25.8, 18.4, −5.4 ppm. HRMS (ESI, m/z): calcd. for [C18H25O4Si]+ (M+H)+, 333.1517; found, 333.1543.
2-(4-(((tert-butyldimethylsilyl)oxy)methyl)-7-(hydroxymethyl)-1,3-dioxo-5-phenoxy-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-2-yl)ethyl 2-bromo-2-methylpropanoate (219). A round bottom flask equipped with a stir bar was charged with 218 (350 mg, 1.05 mmol), THF (4 mL), and MeOH (1 mL). The solution was cooled to 0° C. in an ice bath before slowly adding NaBH4 (52.0 mg, 1.38 mmol). The mixture was kept at 0° C. for 1 h before adding 10% NH4Cl (10 mL) and extracting with DCM (2×10 mL). The organic layer was dried over Na2SO4 and filtered. Maleimide 214 was added to the solution, and then the mixture was concentrated under reduced pressure until about 2 mL viscous solution remaining. The mixture was then stirred at room temperature for 2 h to allow the Diels-Alder reaction to run to completion, and the crude mixture was purified by column chromatography (10-30% EtOAc/Hexanes). A single endo isomer of the title compound was isolated as a colorless oil (478 mg, 73%). 1H NMR (400 MHz, CDCl3) δ 7.37-7.28 (m, 2H), 7.23-7.14 (m, 1H), 7.00-6.93 (m, 2H), 4.95 (s, 1H), 4.35 (ABq, ΔνAB=5.3 Hz, JAB=12.5 Hz, 2H), 4.30-3.98 (m, 4H), 3.86 (d, J=7.8 Hz, 1H), 3.74 (m, 1H), 3.65-3.49 (m, 2H), 2.02 (t, J=6.5 Hz, 1H), 1.87 (d, J=2.4 Hz, 6H), 0.94 (s, 9H), 0.16 (d, J=7.2 Hz, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 175.2, 174.0, 171.5, 163.3, 154.9, 130.1, 125.9, 119.9, 100.6, 90.6, 90.5, 62.6, 62.5, 59.7, 55.7, 50.8, 47.4, 37.4, 30.7, 30.7, 26.1, 18.7, −5.1, −5.2 ppm. HRMS (ESI, m/z): calcd. for [C28H39NO8Si]+ (M+H)+, 624.1623; found, 624.1642.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(((tert-butyldimethylsilyl)oxy)methyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate (220). A flame-dried round bottom flask equipped with a stir bar was charged with 219 (237 mg, 0.380 mmol), Et3N (132 μL, 0.950 mmol) and DCM (10 mL). The solution was cooled to 0° C. before adding α-bromo-isobutyryl bromide (0.11 mL mg, 0.89 mmol) dropwise. The reaction was then allowed to slowly warm to room temperature and stirred overnight until the reaction had completed, as determined by TLC. The reaction mixture was then diluted with DCM (10 mL), washed with NH4Cl (25 mL) and brine (20 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (10-30% EtOAc/hexanes) to yield the title compound as a viscus colorless oil (155 mg, 53% yield). 1H NMR (400 MHz, CDCl3) δ 7.36-7.29 (m, 2H), 7.21-7.15 (m, 1H), 6.99-6.92 (m, 2H), 4.92 (s, 1H), 4.67 (ABq, ΔνAB=124.7 Hz, JAB=12.5 Hz, 2H), 4.34 (ABq, ΔνAB=11.9 Hz, JAB=12.4 Hz, 2H), 4.30-4.10 (m, 2H), 3.85 (d, J=7.8 Hz, 1H), 3.78-3.68 (m, 1H), 3.63 (d, J=7.8 Hz, 1H), 3.60-3.52 (m, 1H), 1.95 (d, J=4.0 Hz, 6H), 1.87 (d, J=1.9 Hz, 6H), 0.93 (s, 9H), 0.14 (d, J=9.4 Hz, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 174.4, 173.8, 171.5, 171.2, 163.5, 154.9, 130.1, 126.0, 119.8, 100.4, 90.5, 88.3, 63.8, 62.6, 59.6, 55.7, 55.6, 50.9, 47.1, 37.4, 30.9, 30.8, 30.7, 30.7, 26.0, 18.6, −5.1, −5.2 ppm. HRMS (ESI, m/z): calcd. for [C32H44Br2NO9Si]+ (M+H)+, 772.1147; found, 772.1168.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(hydroxymethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate (221). A flame-dried round bottom flask equipped with a stir bar was charged with 220 (155 mg, 0.200 mmol) and THF (3 mL). The solution was cooled to 0° C. before adding TBAF (1 M in THF, 0.26 mL, 0.26 mmol) dropwise. The mixture was allowed to slowly warm up room temperature and stirred for 1 h. The reaction mixture was washed with NH4Cl (10 mL), extracted with EtOAc (10 mL), washed with brine (10 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (40-65% EtOAc/hexanes) to yield the title compound as a white foamy solid (105 mg, 80% yield). 1H NMR (400 MHz, CDCl3) δ 7.38-7.30 (m, 2H), 7.23-7.14 (m, 1H), 7.01-6.94 (m, 2H), 4.97 (s, 1H), 4.69 (ABq, ΔνAB=113.7 Hz, JAB=12.6 Hz, 2H), 4.44 (d, J=13.1 Hz, 1H), 4.35-4.22 (m, 2H), 4.2-4.12 (m, 1H), 3.81-3.63 (m, 3H), 3.57 (m, 1H), 1.96 (d, J=4.2 Hz, 6H), 1.86 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 174.0, 173.4, 171.4, 171.1, 163.1, 154.7, 130.0, 126.0, 119.7, 100.6, 90.0, 88.6, 63.4, 62.3, 59.6, 55.5, 55.5, 50.7, 47.8, 37.4, 30.7, 30.6 ppm. HRMS (ESI, m/z): calcd. for [C26H30Br2NO9]+ (M+H)+, 658.0281; found, 658.0287.
The title compound was prepared following the same procedure as that for compound (±)-10(O), with compound 221 (20 mg, 0.030 mmol), dry pyridine (3.2 μL, 0.040 mmol), coumarin chloroformate (9.4 mg, 0.039 mmol) and DCM (5 mL). The crude product was purified by column chromatography (20-50% EtOAc/hexanes) to provide the title compound as a white foamy solid (21 mg, 81%). 1H NMR (400 MHz, CDCl3) δ 7.62 (d, J=8.7 Hz, 1H), 7.36 (dd, J=8.4, 7.4 Hz, 2H), 7.25-7.16 (m, 3H), 7.04-6.95 (m, 2H), 6.3-6.26 (m, 1H), 5.04 (s, 1H), 5.01 (ABq, ΔνAB=75.3 Hz, JAB=12.6 Hz, 2H), 4.71 (ABq, ΔνAB=110.7 Hz, JAB=12.7 Hz, 2H), 4.35-4.25 (m, 1H), 4.23-4.11 (m, 1H), 3.86-3.68 (m, 3H), 3.66-3.55 (m, 1H), 2.43 (d, J=1.2 Hz, 3H), 1.96 (d, J=3.8 Hz, 6H), 1.87 (d, J=1.2 Hz, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.7, 172.9, 171.5, 171.2, 162.2, 160.5, 154.7, 154.3, 153.2, 152.5, 151.9, 130.3, 126.3, 125.7, 119.7, 118.3, 117.5, 114.9, 110.1, 100.8, 89.1, 87.2, 64.5, 63.4, 62.4, 55.7, 55.5, 50.7, 48.5, 37.6, 30.8, 30.7, 18.9 ppm. HRMS (ESI, m/z): calcd. for [C37H36Br2NO13]+ (M+H)+, 860.0548; found, 860.0553.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-((((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)methyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate (22(N)). The title compound was prepared following the same procedure as that for compound (±)-10(N), with compound 221 (40 mg, 0.061 mmol), DMAP (1.0 mg, 0.0082 mmol), coumNCO (18 mg, 0.089 mmol) and CDCl3 (3 mL). The crude produce was purified by column chromatography (20-40% Et2O in 1:1 Hexanes/DCM) to provide the title compound as a white foamy solid (50 mg, 95%). 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J=8.6 Hz, 1H), 7.50-7.38 (m, 2H), 7.38-7.30 (m, 2H), 7.23-7.17 (m, 1H), 7.14 (s, 1H), 7.03-6.95 (m, 2H), 6.22-6.16 (m, 1H), 5.03 (s, 1H), 4.95 ((ABq, ΔνAB=59.3 Hz, JAB=12.7 Hz, 2H), 4.70 (ABq, ΔνAB=108.0 Hz, JAB=12.7 Hz, 2H), 4.34-4.11 (m 2H),3.80-3.67 (m, 3H), 3.64-3.54 (m, 1H), 2.41 (d, J=1.3 Hz, 3H), 1.95 (d, J=3.6 Hz, 6H), 1.86 (d, J=0.8 Hz, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.8, 172.9, 171.6, 171.2, 162.5, 161.1, 154.7, 154.6, 152.3, 152.2, 141.1, 130.2, 126.2, 125.6, 119.6, 115.9, 114.6, 113.5, 106.3, 100.7, 88.9, 87.7, 63.5, 62.4, 61.5, 55.7, 55.6, 50.7, 48.9, 37.6, 30.8, 30.7, 18.7 ppm. HRMS (ESI, m/z): calcd. for [C37H37Br2N2O12]+ (M+H)+, 859.0708; found, 859.0704.
A 2 dram vial equipped with a stir bar was charged with (±)-29 (34.0 mg, 0.0505 mmol), DMAP (1.5 mg, 0.012 mmol), 1-pyrenebutanoic acid (16 mg, 0.056 mmol) and THF (0.5 mL). N,N′-Dicyclohexylcarbodiimide (11.5 mg, 0.0558 mmol) was then added to the reaction mixture slowly. The reaction was stirred at room temperature overnight until the reaction completed, as determined by 1H NMR spectroscopy. The reaction mixture was then diluted with Et2O (15 mL), washed with NH4Cl (15 mL) and brine (15 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (20-40% EtOAc/hexanes) to yield the title compound as a white foamy solid (43.6 mg, 91% yield). 1H NMR (400 MHz, CDCl3) δ 8.35-8.28 (m, 1H), 8.21-8.14 (m, 2H), 8.14-8.08 (m, 2H), 8.05-8.02 (m, 2H), 8.02-7.97 (m, 1H), 7.91-7.85 (m, 1H), 7.35-7.28 (m, 2H), 7.20-7.14 (m, 1H), 6.97-6.91 (m, 2H), 5.77 (q, J=6.5 Hz, 1H), 4.98 (s, 1H), 4.66 (ABq, ΔνAB=119.3 Hz, JAB=12.6 Hz, 2H), 4.28-4.07 (m, 2H), 3.73-3.62 (m, 2H), 3.62-3.50 (m, 2H), 3.44 (t, J=7.7 Hz, 2H), 2.56 (t, J=7.3 Hz, 2H), 2.32-2.20 (m, 2H), 1.90 (d, J=4.2 Hz, 6H), 1.79 (d, J=4.0 Hz, 6H), 1.55 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.8, 172.9, 172.4, 171.5, 171.1, 162.9, 154.7, 135.7, 131.5, 131.0, 130.2, 130.2, 128.9, 127.6, 127.6, 126.9, 126.1, 126.0, 125.2, 125.1, 125.1, 125.0, 124.9, 123.5, 119.7, 100.9, 90.8, 88.3, 66.8, 63.7, 62.4, 55.7, 55.6, 51.4, 47.9, 37.5, 34.1, 32.9, 30.8, 30.7, 30.6, 27.0, 16.0 ppm. HRMS (ESI, m/z): calcd. for [C47H46Br2NO10]+ (M+H)+, 942.1483; found, 942.1509.
1-(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-1,3-dioxo-5-phenoxy-7-((pivaloyloxy)methyl)-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)ethyl 4-(pyren-1-yl)butanoate ((±)-10(COOH-control)). The title compound was prepared following a similar procedure as that for compound (±)-10(COOH), with compound (±)-29-control (23.0 mg, 0.0378 mmol), 1-pyrenebutanoic acid (21.8 mg, 0.0757 mmol), N,N′-dicyclohexylcarbodiimide (15.6 mg, 0.0757 mmol), DMAP (2.3 mg, 0.019 mmol), and THF (0.5 mL). Column chromatography (10-25% EtOAc/Hexanes) followed by preparative thin layer chromatography (4:1 toluene/acetone) afforded the title compound as a white foamy solid (28 mg, 84%). 1H NMR (500 MHz, CDCl3) δ 8.34-8.29 (m, 1H), 8.19-8.14 (m, 2H), 8.14-8.08 (m, 2H), 8.06-8.02 (m, 2H), 8.02-7.96 (m, 1H), 7.89-7.86 (m, 1H), 7.35-7.28 (m, 2H), 7.21-7.14 (m, 1H), 6.95-6.90 (m, 2H), 5.78 (q, J=6.5 Hz, 1H), 4.93 (s, 1H), 4.57 (ABq, ΔνAB=166.4 Hz, JAB=12.7 Hz, 2H), 4.28-4.10 (m, 2H), 3.74-3.61 (m, 2H), 3.61-3.47 (m, 2H), 3.44 (t, J=7.7 Hz, 2H), 2.57 (t, J=7.3 Hz, 2H), 2.32-2.20 (m, 2H), 1.80 (d, J=6.0 Hz, 6H), 1.56 (d, J=6.6 Hz, 3H), 1.18 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 177.8, 173.9, 172.9, 172.4, 171.5, 162.8, 154.7, 135.7, 131.5, 131.0, 130.2, 130.1, 128.9, 127.6, 127.6, 126.9, 126.1, 126.0, 126.0, 125.2, 125.1, 125.1, 125.0, 124.9, 123.5, 119.7, 119.6, 101.1, 90.7, 88.6, 66.8, 62.5, 62.4, 55.7, 51.4, 48.0, 39.0, 37.4, 34.1, 32.9, 30.6, 30.6, 27.3, 27.2, 27.0, 16.0 ppm. HRMS (ESI, m/z): calcd. for [C48H49BrNO10]+ (M+H)+, 878.2534; found, 878.2541.
A 2 dram vial equipped with a stir bar was charged with (±)-29 (22 mg, 0.033 mmol), DMAP (4.2 mg, 0.035 mmol) and CDCl3 (0.3 mL). Naphthalene-2-sulfonyl chloride (7.8 mg, 0.034 mmol) dissolved in CDCl3 (0.2 mL) was then added to the reaction mixture slowly. The solution was then stirred at room temperature until the reaction completed, as determined by 1H NMR spectroscopy (˜2 h). The reaction mixture was then diluted with DCM (10 mL), washed with NH4Cl (15 mL) and brine (15 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (20-40% EtOAc/hexanes) to yield the title compound as a white foamy solid (17.6 mg, 62% yield). 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=1.8 Hz, 1H), 8.07-7.99 (m, 2H), 7.99-7.92 (m, 2H), 7.60-7.73 (m, 2H), 7.38-7.29 (m, 2H), 7.22-7.15 (m, 1H), 6.96-6.89 (m, 2H), 5.55 (q, J=6.6 Hz, 1H), 4.94 (s, 1H), 4.60 (ABq, ΔνAB=107.3 Hz, JAB=12.6 Hz, 2H), 4.21-4.04 (m, 2H), 3.75 (d, J=7.9 Hz, 1H), 3.68-3.49 (m, 3H), 1.92 (d, J=4.6 Hz, 6H), 1.84 (d, J=1.6 Hz, 6H), 1.57 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.6, 172.7, 171.4, 171.1, 162.4, 154.5, 135.5, 133.8, 132.1, 130.2, 130.0, 129.9, 129.6, 129.6, 128.2, 128.0, 126.3, 122.7, 119.6, 101.1, 90.4, 88.4, 75.2, 63.5, 62.3, 55.7, 55.5, 51.3, 47.9, 37.4, 30.8, 30.7, 30.7, 17.2 ppm. HRMS (ESI, m/z): calcd. for [C37H38Br2NO11S]+ (M+H)+, 862.0527; found, 862.0546.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-((naphthalen-2-ylsulfonyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-10(SO3H-control)). The title compound was prepared following the same procedure as that for compound (±)-10(SO3H), with compound (±)-29-control (20 mg, 0.033 mmol), DMAP (6.3 mg, 0.052 mmol), naphthalene-2-sulfonyl chloride (11.7 mg, 0.052 mmol, and CDCl3 (0.5 mL). Column chromatography (25-45% EtOAc/Hexanes) afforded the title compound as a white foamy solid (24 mg, 91%). 1H NMR (400 MHz, CDCl3) δ 8.62 (d, J=1.8 Hz, 1H), 8.05-7.91 (m, 4H), 7.72-7.61 (m, 2H), 7.38-7.28 (m, 2H), 7.23-7.16 (m, 1H), 6.95-6.88 (m, 2H), 5.56 (q, J=6.5 Hz, 1H), 4.89 (s, 1H), 4.50 (ABq, ΔνAB=122.8 Hz, JAB=12.7 Hz, 2H), 4.22-4.06 (m, 2H), 3.75 (d, J=7.9 Hz, 1H), 3.68-3.46 (m, 3H), 1.85 (s, 6H), 1.63-1.52 (m, 3H), 1.19 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 177.8, 173.7, 172.8, 171.4, 162.4, 154.6, 135.5, 133.8, 132.1, 130.2, 130.0, 129.8, 129.6, 129.6, 128.1, 127.9, 126.2, 122.7, 119.6, 101.2, 90.3, 88.7, 75.2, 62.3, 62.2, 55.7, 51.2, 48.0, 39.0, 37.4, 30.7, 30.6, 27.3, 27.2, 17.2 ppm. HRMS (ESI, m/z): calcd. for [C38H40BrNO11SNa]+ (M+Na)+, 820.1398; found, 820.1392.
A 2 dram vial equipped with a stir bar was charged with (±)-29 (101 mg, 0.150 mmol), pyridine (14.6 μL, 0.181 mmol) and CDCl3 (1 mL). 4-nitrophenyl chloroformate (33.3 mg, 0.166 mmol) dissolved in CDCl3 was then added to the reaction mixture slowly. The reaction was then stirred at room temperature until the reaction had completed, as determined by 1H NMR spectroscopy (˜2 h). The reaction mixture was then diluted with DCM (20 mL), washed with NH4Cl (25 mL) and brine (25 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (20-45% EtOAc/Hexanes) to yield the title compound as a white foamy solid (125 mg, quant). 1H NMR (400 MHz, CDCl3) δ 8.34-8.26 (m, 2H), 7.49-7.41 (m, 2H), 7.36 (dd, J=8.5, 7.3 Hz, 2H), 7.21 (t, J=7.5 Hz, 1H), 7.01-6.94 (m, 2H), 5.66 (q, J=6.5 Hz, 1H), 5.03 (s, 1H), 4.71 (ABq, ΔνAB=106.7 Hz, JAB=12.6 Hz, 2H), 4.34-4.12 (m, 2H), 3.87 (d, J=7.8 Hz, 1H), 3.78-3.54 (m, 3H), 1.96 (d, J=2.0 Hz, 6H), 1.86 (d, J=1.2 Hz, 6H), 1.72 (d, J=6.5 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.7, 172.9, 171.5, 171.1, 162.5, 155.6, 154.6, 151.8, 145.6, 130.3, 126.3, 125.5, 121.9, 119.7, 101.2, 90.3, 88.5, 72.9, 63.5, 62.4, 55.7, 55.5, 51.4, 48.1, 37.6, 30.8, 30.7, 30.7, 15.7 ppm. HRMS (ESI, m/z): calcd. for [C34H34Br2N2O13Na]+ (M+Na)+, 859.0320; found, 859.0325.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(1-(((4-nitrophenoxy)carbonyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-223-control). The title compound was prepared following a similar procedure as that for compound (±)-223, with compound (±)-29-control (75.0 mg, 0.123 mmol), pyridine (12.0 μL, 0.149 mmol), 4-nitrophenyl chloroformate (27.3 mg, 0.136 mmol), and CDCl3 (0.7 mL). Column chromatography (20-45% EtOAc/hexanes) afforded the title compound as a white foamy solid (94.5 mg, quant). 1H NMR (500 MHz, CDCl3) δ 8.33-8.27 (m, 2H), 7.48-7.42 (m, 2H), 7.40-7.32 (m, 2H), 7.25-7.18 (m, 1H), 6.99-6.93 (m, 2H), 5.66 (q, J=6.5 Hz, 1H), 4.99 (s, 1H), 4.61 (ABq, ΔνAB=151.1 Hz, JAB=12.8 Hz, 2H), 4.34-4.14 (m, 2H), 3.87 (d, J=7.9 Hz, 1H), 3.75-3.58 (m, 3H), 1.87 (s, 6H), 1.72 (d, J=6.5 Hz, 3H), 1.23 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 177.8, 173.7, 173.0, 171.6, 162.5, 155.6, 154.7, 151.9, 145.6, 130.3, 126.3, 125.5, 121.9, 119.7, 101.4, 90.1, 88.8, 72.8, 62.4, 62.2, 55.7, 51.4, 48.2, 39.1, 37.6, 30.7, 27.3, 15.7 ppm. HRMS (ESI, m/z): calcd. for [C35H37BrN2O13Na]+ (M+Na)+, 795.1371; found, 795.1377.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-7-(1-(((4-(pyren-1-yl)butoxy)carbonyl)oxy)ethyl)-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate ((±)-10(OAlk)). A 2 dram vial equipped with a stir bar was charged with (±)-223 (21.7 mg, 0.0259 mmol), DMAP (3.5 mg, 0.029 mmol) and CDCl3 (0.5 mL), followed by the addition of 1-pyrenebutanol (7.8 mg, 0.028 mmol) dissolved in CDCl3 (0.2 mL). The reaction was stirred at 50° C. overnight until the reaction had completed, as determined by 1H NMR spectroscopy. The reaction mixture was then diluted with DCM (15 mL), washed with NH4Cl (15 mL) and brine (15 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (35-50% EtOAc/hexanes) to yield the title compound as a white foamy solid (18 mg, 72% yield). 1H NMR (400 MHz, CDCl3) δ 8.30-7.85 (m, 9H), 7.39-7.29 (m, 2H), 7.21-7.13 (m, 1H), 7.01-6.91 (m, 2H), 5.57 (q, J=6.5 Hz, 1H), 4.99 (s, 1H), 4.66 (ABq, ΔνAB=109.8 Hz, JAB=12.6 Hz, 2H), 4.36-4.17 (m, 3H), 4.16-4.08 (m, 1H), 3.81 (d, J=7.9 Hz, 1H), 3.70-3.51 (m, 3H), 3.40 (t, J=7.5 Hz, 2H), 2.13-1.85 (m, 10H), 1.82 (s, 6H), 1.58 (d, J=6.5, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.7, 172.9, 171.4, 171.0, 162.5, 154.6, 154.5, 136.2, 131.4, 130.9, 130.1, 129.9, 128.6, 127.5, 127.4, 127.3, 126.7, 126.0, 125.9, 125.1, 125.0, 124.9, 124.8, 124.8, 123.3, 119.5, 101.0, 90.5, 88.2, 70.3, 68.3, 63.6, 62.3, 55.5, 55.5, 51.3, 47.7, 37.3, 33.0, 30.7, 30.6, 30.5, 28.7, 27.9, 15.8 ppm. HRMS (ESI, m/z): calcd. for [C48H48Br2NO11]+ (M+H)+, 972.1589; found, 972.1597.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-7-(1-(((4-(pyren-1-yl)butoxy)carbonyl)oxy)ethyl)-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-10(OAlk-control)). The title compound was prepared following a similar procedure as that for compound (±)-10(OAlk), with compound (±)-223-control (30.0 mg, 0.0388 mmol), DMAP (9.5 mg, 0.078 mmol), 1-pyrenebutanol (21.3 mg, 0.777 mmol), and CDCl3 (0.5 mL). Column chromatography (20-50% EtOAc/Hexanes) afforded the title compound as a white foamy solid (25.9 mg, 73%). 1H NMR (400 MHz, CDCl3) δ 8.30-7.85 (m, 9H), 7.37-7.29 (m, 2H), 7.22-7.15 (m, 1H), 7.00-6.91 (m, 2H), 5.56 (q, J=6.5 Hz, 1H), 4.94 (s, 1H), 4.56 (ABq, ΔνAB=123.5 Hz, JAB=12.7 Hz, 2H), 4.34-4.19 (m, 3H), 4.17-4.08 (m, 1H), 3.80 (d, J=7.9 Hz, 1H), 3.70-3.49 (m, 3H), 3.40 (t, J=7.5 Hz, 2H), 2.15-1.73 (m, 10H), 1.58 (d, J=6.5 Hz, 3H), 1.20 (s, 9H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 177.9, 173.9, 173.1, 171.5, 162.6, 154.7, 136.3, 131.6, 131.0, 130.2, 130.0, 128.8, 127.6, 127.5, 127.4, 126.8, 126.1, 126.0, 125.2, 125.1, 125.1, 125.0, 124.9, 123.4, 119.7, 101.2, 90.5, 88.7, 70.5, 68.4, 62.4, 55.7, 51.4, 47.8, 39.0, 37.4, 33.2, 30.7, 28.8, 28.0, 27.2, 27.2, 15.9 ppm. HRMS (ESI, m/z): calcd. for [C49H51BrNO11]+ (M+H)+, 908.2640; found, 908.2626.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-7-(1-(((pyren-1-ylmethyl)carbamoyl)oxy)ethyl)-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl 2-bromo-2-methylpropanoate ((±)-10(NAlk)). A 2 dram vial equipped with a stir bar was charged with (±)-223 (24.1 mg, 0.0289 mmol), DMAP (8.4 mg, 0.069 mmol) and CDCl3 (0.5 mL). Pyren-1-ylmethanamine hydrochloride (8.5 mg, 0.032 mmol) dissolved in CDCl3 (0.5 mL) was then added to the reaction mixture. The reaction was stirred at 50° C. overnight until the reaction had completed, as determined by 1H NMR spectroscopy. The reaction mixture was then diluted with DCM (10 mL), washed with NH4Cl (15 mL) and brine (15 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography (20-60% EtOAc/hexanes) to yield the title compound as a white foamy solid (20 mg, 74% yield). 1H NMR (500 MHz, CDCl3) δ 8.34-7.97 (m, 9H), 7.32-7.26 (m, 2H), 7.19-7.13 (m, 1H), 6.93 (d, J=7.9 Hz, 2H), 5.77 (q, J=6.5 Hz, 1H), 5.38-5.30 (m, 1H), 5.16 (d, J=5.6 Hz, 2H), 4.96 (s, 1H), 4.63 (ABq, ΔνAB=137.0 Hz, JAB=12.6 Hz, 2H), 4.34-4.19 (m, 1H), 4.18-4.08 (m, 1H), 3.77 (d, J=7.9 Hz, 1H), 3.71-3.41 (m, 3H), 1.91 (d, J=3.7 Hz, 6H), 1.82 (s, 6H), 1.57 (d, J=6.5 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.9, 172.9, 171.5, 171.1, 163.1, 155.3, 154.7, 131.4, 131.2, 130.9, 130.1, 129.1, 128.4, 127.7, 127.5, 127.0, 126.3, 126.0, 125.6, 125.5, 125.2, 125.0, 124.9, 122.9, 119.7, 100.7, 90.9, 88.3, 67.3, 63.7, 62.5, 55.7, 55.6, 51.3, 47.8, 43.7, 37.5, 30.8, 30.7, 30.7, 16.3 ppm. HRMS (ESI, m/z): calcd. for [C45H43Br2N2O10]+ (M+H)+, 929.1279; found, 929.1268.
(2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-1,3-dioxo-6-phenoxy-7-(1-(((pyren-1-ylmethyl)carbamoyl)oxy)ethyl)-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)methyl pivalate ((±)-10(NAlk-control)). The title compound was prepared following a similar procedure as that for compound (±)-10(NAlk), with compound (±)-223-control (38.0 mg, 0.0491 mmol), DMAP (13.2 mg, 0.108 mmol), pyren-1-ylmethanamine hydrochloride (14.5 mg, 0.0542 mmol), and CDCl3 (0.5 mL). Column chromatography (20-40% EtOAc/hexanes) afforded the title compound as a white foamy solid (41 mg, 96%). 1H NMR (400 MHz, CDCl3) δ 8.35-7.92 (m, 9H) 7.29 (t, J=7.7 Hz, 2H), 7.16 (t, J=7.4 Hz, 1H), 6.92 (d, J=7.9 Hz, 2H), 5.77 (q, J=6.4 Hz, 1H), 5.34 (t, J=5.6 Hz, 1H), 5.15 (d, J=5.5 Hz, 2H), 4.91 (s, 1H), 4.53 (ABq, ΔνAB=124.2 Hz, JAB=12.7 Hz, 2H), 4.30-4.19 (m, 1H), 4.20-4.08 (m, 1H), 3.76 (d, J=7.9 Hz, 1H), 3.72-3.50 (m, 2H), 3.46 (d, J=7.9 Hz, 1H), 1.82 (d, J=0.9 Hz, 6H), 1.56 (d, J=6.5 Hz, 3H), 1.17 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 177.8, 173.9, 173.0, 171.5, 163.0, 155.3, 154.8, 131.4, 131.2, 130.9, 130.1, 129.0, 128.4, 127.7, 127.5, 127.0, 126.2, 126.0, 125.6, 125.5, 125.1, 124.9, 124.8, 122.9, 119.6, 100.8, 90.8, 88.6, 67.4, 62.5, 62.4, 55.7, 51.3, 47.9, 43.7, 39.0, 37.4, 30.7, 30.7, 27.2, 16.3 ppm. HRMS (ESI, m/z): calcd. for [C46H46BrN2O10]+ (M+H)+, 865.2330; found, 865.2338.
A round bottom flask equipped with a stir bar was charged with 27 (0.916 g, 3.95 mmol) and methanol (10 mL). The solution was cooled to 0° C. in an ice bath followed by the slow addition of NaBH4 (0.246 g, 6.47 mmol). The reaction mixture was allowed to slowly warm to room temperature and stirred for 1 h. The mixture was then washed with 10% NH4Cl (20 mL) and extracted with DCM (2×20 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under reduced pressure to yield 1-(5-(hydroxymethyl)-3-phenoxyfuran-2-yl)ethan-1-ol as a colorless oil, which was used in the next step without further purification. The intermediate diol is stable for approximately one month when stored at −20° C.
A flame-dried round bottom flask equipped with a stir bar was charged with 1-(5-(hydroxymethyl)-3-phenoxyfuran-2-yl)ethan-1-ol (365.2 mg, 1.559 mmol), Et3N (228 μL, 1.64 mmol) and DCM (10 mL). The solution was cooled to 0° C. before adding pivaloyl chloride (202 μL, 1.64 mmol) dropwise. The reaction was then allowed to slowly warm to room temperature and stirred for approximately 4 h. The reaction mixture was then washed with NH4Cl (10 mL) and brine (10 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude product was purified by column chromatography using 3:1 hexanes/EtOAc to yield the title compound as a colorless oil (315 mg, 60% yield over two steps). 1H NMR (400 MHz, CDCl3) δ 7.33-7.24 (m, 2H), 7.07-7.01 (m, 1H) 7.02-6.93 (m, 2H), 6.19 (s, 1H), 4.97 (ABq, ΔνAB=8.19 Hz, JAB=14.2 Hz, 2H), 4.92 (q, J=6.7 Hz, 1H), 2.36 (s, 1H), 1.53 (d, J=6.8 Hz, 3H), 1.20 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 178.2, 158.0, 147.9, 145.1, 138.8, 129.7, 122.8, 116.2, 106.5, 61.3, 58.6, 38.9, 27.2, 26.6, 20.7 ppm. HRMS (ESI, m/z): calcd. for [C18H21O4]+ (M−H2O)+, 301.1434; found, 301.1455.
(5-(1-(((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)ethyl)-4-phenoxyfuran-2-yl)methyl pivalate (21). A flamed-dried two-neck round bottom flask equipped with a stir bar was charged with 224 (77.2 mg, 0.243 mmol), coumNCO (81.8 mg, 0.407 mmol), and DCM (8 mL). DMAP (8.1 mg, 0.066 mmol) was then added into the stirred mixture at 0° C., and the reaction was allowed to warm to room temperature. After 3 h, the reaction was quenched by adding a solution of glucose (35.0 mg, 0.194 mmol) in 3 mL DMF. The mixture was stirred at room temperature for 2 h to consume the excess coumNCO completely, then diluted with diethyl ether (20 mL) and hexane (5 mL). A precipitate appeared immediately and the suspension was filtered to remove the excess glucose and any other insoluble products. The filtrate was washed with aqueous NaHCO3 solution and brine, dried over Na2SO4, then concentrated. The crude material was again dispersed into a mixture of diethyl ether (5 mL) and hexane (10 mL), and then filtered to remove insoluble 7-amino-4-methylcoumarin. The filtrate was concentrated, dissolved in a small amount of DCM (0.3 mL), and then added into a mixture of diethyl ether (3 mL) and hexane (7 mL). The mixture was slowly concentrated to around half of its original volume using a rotary evaporator causing a white precipitate to form. The white solid was collected carefully by removing the solution using a pipet, then washed with hexane, and finally dried under high vacuum to yield metastable compound 21 as a fluffy white solid (45.5 mg, 36%). 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J=8.6 Hz, 1H), 7.36-7.27 (m, 4H), 7.05 (t, J=7.4 Hz, 1H), 7.00 (d, J=8.1 Hz, 2H), 6.73 (s, 1H), 6.23 (s, 1H), 6.18 (d, J=1.3 Hz, 1H), 6.02 (q, J=6.7 Hz, 1H), 5.00 (ABq, ΔνAB=17.7 Hz, JAB=13.5 Hz, 2H), 2.41 (d, J=1.2 Hz, 3H), 1.67 (d, J=6.7 Hz, 3H), 1.22 (s, 9H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ 178.2, 161.2, 157.9, 154.6, 152.3, 152.0, 148.9, 141.4, 141.0, 140.9, 129.8, 125.5, 123.1, 116.6, 115.7, 114.4, 113.3, 106.5, 106.0, 65.0, 58.6, 39.0, 27.2, 18.7, 18.2 ppm. HRMS (FAB, m/z): calcd. for [C29H30NO8]+ (M+H)+, 520.1966; found, 520.1950.
Compound 21 (6.2 mg, 0.012 mmol) was dissolved in a mixture of MeOH (155 mL) and MeCN (465 mL) and stirred at room temperature. After 16 h, the reaction mixture was concentrated under reduced pressure and the crude product was purified by flash chromatography ((±)-20% EtOAc/hexanes) to provide the title compound as a colorless oil (3.0 mg, 75%). 1H NMR (400 MHz, CDCl3) δ 7.39-7.27 (m, 2H), 7.08-7.03 (m, 1H), 7.02-6.96 (m, 2H), 6.22 (d, J=0.6 Hz, 1H), 5.00 (ABq, ΔνAB=11.6 Hz, JAB=13.4 Hz, 2H), 4.44 (q, J=6.7 Hz, 1H), 3.24 (s, 3H), 1.51 (d, J=6.7 Hz, 3H), 1.20 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 178.2, 158.1, 148.5, 142.8, 141.0, 129.8, 122.9, 116.4, 106.0, 69.2, 58.7, 56.3, 39.0, 27.2, 18.8 ppm. HRMS (FAB, m/z): calcd. for [C19H24O5]+ (M)+, 332.1624; found, 332.1645.
A flame-dried round bottom flask equipped with a stir bar was charged with 1-(5-(hydroxymethyl)furan-2-yl)ethan-1-ol (1.00 g, 7.04 mmol), Et3N (1.30 mL, 9.44 mmol) and DCM (10 mL). The solution was cooled to 0° C. before adding pivaloyl chloride (1.0 mL mg, 8.13 mmol) dropwise. The reaction was then allowed to slowly warm to room temperature and stirred overnight until the reaction completed, as determined by 1H NMR spectroscopy. The reaction mixture was then washed with NH4Cl (10 mL) and brine (10 mL), and the organic fraction was dried over Na2SO4, filtered, and concentrated under reduced pressure to afford (5-(1-hydroxyethyl)furan-2-yl)methyl pivalate as a light-yellow oil (0.79 g, 50% yield) which was used in the next step without further purification.
A flamed-dried two-neck round bottom flask equipped with a stir bar was charged with (5-(1-hydroxyethyl)furan-2-yl)methyl pivalate (195.8 mg, 0.865 mol), coumNCO (233.0 mg, 1.159 mol), DCM (10 mL), and then DMAP (11.2 mg, 0.0918 mmol). The reaction was kept at room temperature for 3 h. The mixture was then washed with 10% NH4Cl, brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude produce was purified by column chromatography (25-45% EtOAc/hexanes) to provide the title compound as a white solid (296 mg, 80%). 1H NMR (400 MHz, CDCl3) δ 7.51 (d, J=8.6 Hz, 1H), 7.42 (d, J=2.3 Hz, 1H), 7.35 (dd, J=8.6, 2.2 Hz, 1H), 6.87 (broad, 1H), 6.36-6.32 (m, 2H), 6.19 (q, J=1.3 Hz, 1H), 5.96 (q, J=6.7 Hz, 1H), 5.05 (ABq, ΔνAB=12.6 Hz, JAB=13.3 Hz, 2H), 2.40 (d, J=1.2 Hz, 3H), 1.66 (d, J=6.7 Hz, 3H), 1.19 (s, 9H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 178.3, 161.2, 154.6, 153.5, 152.3, 152.3, 150.3, 141.5, 125.5, 115.7, 114.5, 113.3, 110.7, 109.2, 106.1, 66.7, 58.3, 39.0, 27.2, 18.7, 18.5 ppm. HRMS (FAB, m/z): calcd. for [C23H26NO7]+ (M+H)+, 428.1704; found, 428.1723.
The title compound was prepared following a similar procedure as that for compound (±)-10(N), with compound (±)-216 (46.1 mg, 79.3 mmol), DMAP (1.0 mg, 8.2 mmol), coumNCO (31.8 mg, 158.1 mmol) and DCM (1 mL). Column chromatography (20-40% Et2O in 1:1 Hexanes/DCM) afforded the title compound as a white foamy solid (55.6 mg, 90%). 1H NMR (400 MHz, CDCl3) δ 7.53 (d, J=8.7 Hz, 1H), 7.47-7.36 (m, 2H), 7.10 (s, 1H), 6.53-6.40 (m, 2H), 6.19 (q, J=1.3 Hz, 1H), 5.57 (q, J=6.6 Hz, 1H), 4.80 (ABq, ΔνAB=86.5 Hz, JAB=12.6 Hz, 2H), 4.22 (t, J=5.1 Hz, 2H), 3.80-3.61 (m, 3H), 3.56 (d, J=7.8 Hz, 1H), 2.41 (d, J=1.3 Hz, 3H), 1.93 (d, J=6.8 Hz, 6H), 1.90 (s, 6H), 1.53 (d, J=6.6 Hz, 3H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 173.7, 173.6, 171.5, 171.2, 161.1, 154.6, 152.3, 152.0, 141.2, 135.7, 135.3, 125.6, 115.8, 114.5, 113.5, 106.1, 92.8, 89.4, 69.6, 63.2, 62.6, 55.7, 55.5, 49.4, 48.1, 37.7, 30.8, 30.8, 18.7, 16.2 ppm. HRMS (ESI, m/z): calcd. for [C32H34Br2N2O11Na]+ (M+Na)+, 803.0422; found, 803.0427.
A round bottom flask equipped with a stir bar was charged with 5-bromo-2-furaldehyde (1.0 g, 5.7 mmol), 4-(2-hydroxyethyl)phenol (1.0 g, 7.4 mmol), and Cs2CO3 (2.4 g, 7.4 mmol). The flask was purged with N2 before DMF (11 mL) was added. The solution was then heated and kept at 55° C. in an oil bath for 4 h. The reaction was then cooled to room temperature before 10% NH4Cl (50 mL) was added. The mixture was then extracted with Et2O (3×50 mL) and the combined organic phase was washed with brine (150 mL). The organic layer was dried over MgSO4, filtered, and concentrated under reduced pressure. The crude mixture was then purified by column chromatography (30-60% EtOAc/hexanes) to afford the title compound as a yellow oil, which solidified upon storage in the freezer (1.14 g, 86% yield). 1H NMR (400 MHz, CDCl3) δ: 9.38 (s, 1H), 7.30-7.23 (m, 1H), 7.21 (d, J=3.8 Hz, 1H), 7.15-7.06 (m, 1H), 5.55 (d, J=3.8 Hz, 1H), 3.87 (t, J=6.6 Hz, 2H), 2.88 (t, J=6.6 Hz, 2H), 1.68 (s, 1H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 175.7, 163.1, 152.8, 144.8, 136.6, 130.6, 125.2, 119.1, 89.8, 63.4, 38.4 ppm. HRMS (FAB, m/z): calcd. for [C13H13O4]+ (M+H)+, 233.0808; found, 233.0814.
4-((5-formylfuran-2-yl)oxy)phenethyl 2-bromo-2-methylpropanoate (32). A round bottom flask equipped with a stir bar was charged with 1 (1.96 g, 8.45 mmol), DCC (2.09 g, 10.1 mmol), DMAP (257 mg, 2.11 mmol), and THF (11 mL). The solution was then stirred to dissolve all reagents before α-bromo-isobutyric acid was added (1.55 g, 9.28 mmol). The solution was stirred at room temp overnight and then the solid precipitate was filtered off and discarded. The filtrate was diluted with Et2O (10 mL) and washed consecutively with 10% NH4Cl (20 mL) and brine (15 mL). The organic layer was then dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude mixture was purified by column chromatography (20-40% EtOAc/hexanes) to afford the title compound as a dark yellow oil, which solidified upon storage in the freezer (2.48 g, 77% yield). 1H NMR (400 MHz, CDCl3) δ: 9.40 (s, 1H), 7.28 (app d, J=8.3 Hz, 2H), 7.21 (d, J=3.8 Hz, 1H), 7.12 (app d, J=8.3 Hz, 2H), 5.54 (d, J=3.7 Hz, 1H), 4.38 (t, J=6.8 Hz, 2H), 3.01 (t, J=6.8 Hz, 2H), 1.89 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 175.9, 171.7, 163.0, 153.2, 145.0, 135.5, 130.8, 125.5 119.3, 89.9, 66.3, 55.8, 34.3, 30.9 ppm. HRMS (FAB, m/z): calcd. for [C17H18BrO5]+ (M+H)+, 381.0332; found, 381.0335.
4-((2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(hydroxymethyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)oxy)phenethyl 2-bromo-2-methylpropanoate ((±)-33). A flame-dried round bottom flask equipped with a stir bar was charged with 32 (152 mg, 0.40 mmol), DCM (2 mL), and MeOH (2 mL). The solution was cooled to −78° C. in an acetone/dry ice bath before adding NaBH4 (82.0 mg, 2.17 mmol) in three portions. The mixture was kept at −78° C. overnight before being quenched with 10% NH4Cl (10 mL) and subsequently warmed to room temperature. The solution was then extracted with EtOAc (2×10 mL) and the organic phase was washed with brine (10 mL). The organic layer was dried over Na2SO4, and filtered. 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl 2-bromo-2-methylpropanoate (M. Ronn, et al., Synlett, 2012, 134-136, the disclosure of which is incorporated herein by reference) (150 mg, 0.52 mmol) was then added to the filtrate, which was then concentrated under reduced pressure until ˜2 mL of viscous solution remained. The solution was then reacted at room temperature for 12 h, and the crude mixture was purified by column chromatography (40-70% EtOAc/hexanes). A racemic mixture of the endo diastereomer of the title compound was isolated as a foamy white solid (210 mg, 78% yield). 1H NMR (400 MHz, CDCl3) δ: 7.17 (s, 4H), 6.45 (d, J=5.8 Hz, 1H), 6.41 (d, J=5.8 Hz, 1H), 4.35 (m, 2H), 4.31-4.12 (m, 4H), 3.73-3.64 (m, 4H), 2.96 (t, J=6.9 Hz, 2H), 2.05 (m, 1H), 1.90 (d, J=1.2 Hz, 6H), 1.88 (s, 6H) ppm. 13C{1H} NMR (125 MHz, CDCl3) δ: 174.4, 173.4, 171.7, 171.5, 153.2, 135.7, 135.7, 134.0, 130.1, 120.9, 113.5, 86.7, 66.4, 62.6, 61.9, 55.9, 55.6, 50.6, 48.9, 37.7, 34.2, 30.9, 30.8 ppm. HRMS (FAB, m/z): calcd. for [C27H32Br2NO9]+ (M+H)+, 672.0438; found, 672.0459.
4-((2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-(((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)methyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)oxy)phenethyl 2-bromo-2-methylpropanoate ((±)-4O). A round bottom flask equipped with a stir bar was charged with (±)-33 (188 mg, 0.282 mmol) and DCM (15 mL). The solution was cooled to 0° C. in an ice bath before adding 4-methylcoumarin-7-chloroformate (153 mg, 0.845 mmol) in DCM (10 mL), then anhydrous pyridine (68 μL, 0.85 mmol). The mixture was then warmed to room temperature, and stirred for 1 h. The mixture was then washed with 10% NH4Cl (10 mL), extracted with EtOAc (10 mL), and washed with brine (10 mL). The organic layer was dried over Na2SO4, and filtered. The crude mixture was purified by column chromatography (40-70% EtOAc/hexanes) to afford the titled compound as a white foamy solid (228 mg, 92% yield). 1H NMR (400 MHz, CDCl3) δ: 7.64 (d, J=8.7 Hz, 1H), 7.29 (d, J=2.3 Hz, 1H), 7.23 (dd, J=8.7, 2.4 Hz, 1H), 7.19 (s, 4H), 6.51 (d, J=5.8 Hz, 1H), 6.46 (d, J=5.8 Hz, 1H), 6.30 (d, J=1.4 Hz, 1H), 4.89 (ABq, ΔνAB=87.2 Hz, JAB=12.0 Hz, 2H), 4.43-4.31 (m, 2H), 4.25 (t, J=5.1 Hz, 2H), 3.78-3.67 (m, 4H), 2.97 (t, J=6.9 Hz, 2H), 2.45 (d, J=1.2 Hz, 3H), 1.90 (s, 6H), 1.88 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 173.6, 173.0, 171.7, 171.5, 160.5, 154.3, 153.2, 153.2, 152.8, 151.9, 136.1, 135.0, 134.2, 130.2, 125.8, 121.1, 118.4, 117.5, 115.0, 113.6, 110.2, 83.7, 66.4, 66.3, 62.6, 55.9, 55.6, 50.1, 49.7, 37.8, 34.3, 30.9, 30.8, 18.9 ppm. HRMS (FAB, m/z): calcd. for [C38H38Br2NO13]+ (M+H)+, 874.0704; found, 874.0719.
4-((2-(2-((2-bromo-2-methylpropanoyl)oxy)ethyl)-7-((((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)methyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)oxy)phenethyl 2-bromo-2-methylpropanoate ((±)-4NH). A round bottom flask equipped with a stir bar was charged with (±)-33 (100 mg, 0.149 mmol) and DCM (2 mL). The solution was cooled to 0° C. in an ice bath before adding 4-methylcoumarin-7-isocyanate (38.9 mg, 0.845 mmol) and then DMAP (1.8 mg, 0.015 mmol). The mixture was warmed to room temperature and stirred for 1 h. The mixture was then washed with 10% NH4Cl (10 mL), extracted with EtOAc (10 mL), and the organic phase was washed with brine (10 mL). The organic layer was dried over Na2SO4 and filtered. The crude mixture was purified by column chromatography (70-100% EtOAc/hexanes) to afford the title compound as a white foamy solid (113 mg, 87% yield). 1H NMR (400 MHz, CDCl3) δ: 7.5 (d, J=8.7 Hz, 1H), 7.49 (d, J=2.2 Hz, 1H), 7.43 (dd, J=8.7, 2.2 Hz, 1H), 7.30 (s, 1H), 7.16 (s, 4H), 6.47 (d, J=5.7 Hz, 1H), 6.43 (d, J=5.8 Hz, 1H), 6.22-6.19 (m, 1H), 4.82 (ABq, ΔνAB=79.1 Hz, JAB=12.0 Hz, 2H), 4.34 (t, J=6.9 Hz, 2H), 4.28-4.15 (m, 2H), 3.78-3.61 (m, 4H), 2.94 (t, J=6.9 Hz, 2H), 2.41 (d, J=1.2 Hz, 3H), 1.89 (d, J=1.3 Hz, 6H), 1.87 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 173.5, 173.1, 171.7, 171.5, 161.1, 154.6, 153.1, 152.3, 152.3, 141.2, 135.8, 135.4, 134.2, 130.2, 125.6, 121.1, 115.9, 114.6, 113.6, 113.5, 106.3, 84.3, 66.4, 63.2, 62.6, 55.9, 55.7, 50.1, 49.6, 37.7, 34.2, 30.9, 30.8, 18.7 ppm. HRMS (FAB, m/z): calcd. for [C38H39Br2N2O12]+ (M+H)+, 873.0864; found, 873.0898.
The title compound was prepared following a similar procedure as that for compound (±)-33, with compound 32 (500 mg, 1.32 mmol), NaBH4 (100 mg, 2.63 mmol), and N-methylmaleimide (175 mg, 1.58 mmol). The crude mixture was purified by column chromatography (40-70% EtOAc/hexanes). A racemic mixture of the endo diastereomer of the title compound was isolated as a foamy white solid (566 mg, 87% yield). 1H NMR (400 MHz, CDCl3) δ: 7.17 (s, 4H), 6.39 (d, J=5.8 Hz, 1H), 6.35 (d, J=5.8 Hz, 1H), 4.39-4.31 (m, 2H), 4.28 (dd, J=12.6, 5.4 Hz, 1H), 4.17 (dd, J=12.6, 7.0 Hz, 1H), 3.72-3.62 (m, 2H), 2.95 (t, J=6.9 Hz, 2H), 2.85 (s, 3H), 2.22-2.14 (m, 1H), 1.88 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 174.8, 173.8, 171.7, 153.3, 135.7, 135.6, 133.9, 130.1, 120.9, 113.5, 86.6, 66.4, 61.9, 55.9, 50.6, 49.0, 34.2, 30.9, 24.9 ppm. HRMS (FAB, m/z): calcd. for [C22H25BrNO7]+ (M+H)+, 494.0809; found, 494.0799.
4-((2-methyl-7-(((((4-methyl-2-oxo-2H-chromen-7-yl)oxy)carbonyl)oxy)methyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)oxy)phenethyl 2-bromo-2-methylpropanoate ((±)-4O-Con). The title compound was prepared following a similar procedure as that for compound (±)-4O, with compound (±)-33-Con (44 mg, 0.089 mmol), 4-methylcoumarin-7-chloroformate (30.0 mg, 0.125 mmol), anhydrous pyridine (13 μL, 0.13 mmol), and DCM (6 mL). The crude mixture was purified by column chromatography (40-70% EtOAc/hexanes) to afford the title compound as a foamy white solid (34 mg, 55% yield). 1H NMR (500 MHz, CDCl3) δ: 7.64 (d, J=8.7 Hz, 1H), 7.29 (d, J=2.3 Hz, 1H), 7.22 (dd, J=8.7, 2.3 Hz, 1H), 7.19 (s, 4H), 6.45 (d, J=5.8 Hz, 1H), 6.40 (d, J=5.8 Hz, 1H), 6.29 (s, 1H), 4.89 (ABq, ΔνAB=99.5 Hz, JAB=10.0 Hz, 2H), 4.39-4.31 (m, 2H), 3.73 (s, 2H), 2.96 (t, J=6.9 Hz, 2H), 2.88 (s, 3H), 2.45 (s, 3H), 1.88 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 173.9, 173.4, 171.7, 160.5, 154.3, 153.2, 153.2, 152.8, 151.9, 136.0, 134.9, 134.1, 130.2, 125.7, 121.0, 118.4, 117.5, 114.9, 113.5, 110.2, 83.6, 66.4, 66.4, 55.9, 50.1, 49.7, 34.2, 30.9, 25.0, 18.9 ppm. HRMS (FAB, m/z): calcd. for [C33H31BrNO11]+ (M+H)+, 696.1075; found, 696.1060.
4-((2-methyl-7-((((4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl)oxy)methyl)-1,3-dioxo-1,2,3,3a,7,7a-hexahydro-4H-4,7-epoxyisoindol-4-yl)oxy)phenethyl 2-bromo-2-methylpropanoate ((±)-4NH-Con). The title compound was prepared following a similar procedure as that for compound (±)-4NH, with compound (±)-33-Con (100 mg, 0.2 mmol), 4-methylcoumarin-7-isocyanate (52.9 mg, 0.263 mmol), DMAP (2.4 mg, 0.020 mmol), and DCM (3 mL). The crude mixture was purified by column chromatography (50-100% EtOAc/hexanes) to afford the title compound as a foamy white solid (121 mg, 87% yield). 1H NMR (400 MHz, CDCl3) δ: 7.55 (d, J=8.7 Hz, 1H), 7.48 (d, J=2.1 Hz, 1H), 7.43 (dd, J=8.6, 2.2 Hz, 1H), 7.29 (s, 1H), 7.19-7.13 (m, 4H), 6.41 (d, J=5.8 Hz, 1H), 6.38 (d, J=5.8 Hz, 1H), 6.22-6.19 (m, 1H), 4.83 (ABq, ΔνAB=66.9 Hz, JAB=12.0 Hz, 2H), 4.34 (t, J=6.9 Hz, 2H), 3.73 (d, J=7.9 Hz, 1H), 3.66 (d, J=7.9 Hz, 1H), 2.94 (t, J=6.9 Hz, 2H), 2.86 (s, 3H), 2.41 (d, J=1.3 Hz, 3H), 1.87 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ: 174.0, 173.6, 171.7, 161.1, 154.6, 153.2, 152.3, 141.2, 135.8, 135.3, 134.1, 130.2, 125.6, 121.0, 116.0, 114.6, 113.5, 106.3, 84.2, 66.4, 63.3, 55.9, 50.2, 49.6, 34.2, 30.9, 25.0, 18.7 ppm. HRMS (FAB, m/z): calcd. for [C33H32BrN2O10]+ (M+H)+, 695.1235; found, 695.1262.
A 20 mL flame-dried vial equipped with a stir bar was charged with 32 (104 mg, 0.272 mmol), MeOH (2 mL), and DCM (2 mL). The solution was cooled to −78° C. in an acetone/dry ice bath before adding NaBH4 (82.0 mg, 2.17 mmol) in three portions. The mixture was kept at −78° C. overnight before being quenched with 10% NH4Cl (10 mL) and warmed up to room temperature. The solution was then extracted with EtOAc (2×10 mL) and the organic phase was washed with brine (10 mL). The organic layer was dried over Na2SO4, filtered, and concentrated under vacuum. The crude product was then redissolved in DCM (2 mL) and cooled to 0° C. in an ice bath before adding 4-methylcoumarin-7-isocyanate (72.8 mg, 0.353 mmol), followed by DMAP (1.0 mg, 0.031 mmol). The reaction mixture was warmed to room temperature and stirred for 2 h before being quenched by adding a solution of glucose (35.0 mg, 0.194 mmol) in 3 mL DMF. The mixture was stirred at room temperature for 2 h to consume the excess isocyanate, then diluted with diethyl ether (20 mL) and hexane (5 mL). A precipitate appeared immediately and the suspension was filtered to remove the excess glucose and other insoluble products. The filtrate was washed with aqueous NaHCO3 solution and brine, dried over Na2SO4, then concentrated. The crude material was again dispersed into a mixture of diethyl ether (5 mL) and hexane (10 mL), and then filtered to remove insoluble 7-amino-4-methylcoumarin. The filtrate was concentrated, dissolved in a small amount of DCM (0.3 mL), and then added into a mixture of diethyl ether (3 mL) and hexane (7 mL). The mixture was slowly concentrated to around half the original volume using a rotary evaporator causing an off-white precipitate to form. The off-white solid was collected carefully by removing the liquid using a pipet, and then the solid was washed with hexane and finally dried under high vacuum to yield metastable compound 35 a fluffy white solid (53 mg, 34% yield). 1H NMR (500 MHz, CDCl3) δ 7.52 (d, J=8.7 Hz, 1H), 7.47-7.44 (m, 1H), 7.35 (app d, J=8.5 Hz, 1H), 7.23-7.19 (m, 2H), 7.04-6.99 (m, 3H), 6.44 (d, J=3.2 Hz, 1H), 6.19 (s, 1H), 5.49 (d, J=3.3 Hz, 1H), 5.09 (s, 2H), 4.36 (t, J=6.8 Hz, 2H), 2.97 (t, J=6.8 Hz, 2H), 2.41 (s, 3H), 1.90 (s, 6H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 171.7, 161.2, 157.5, 155.2, 154.6, 152.5, 152.3, 141.3, 133.7, 130.5, 125.5, 121.7, 117.6, 115.8, 114.5, 113.4, 113.2, 106.1, 89.5, 66.5, 59.5, 55.9, 34.2, 30.9, 18.7 ppm. HRMS (FAB, m/z): calcd. for [C28H27BrNO8]+ (M+H)+, 584.0915; found, 584.0916.
General Polymerization Procedures. A 10 mL Schlenk flask equipped with a stir bar was charged with the initiator (1 equiv), methyl acrylate (1,500 equiv), Me6TREN (2 equiv), and DMSO (equal volume to methyl acrylate). The flask was sealed, the solution was deoxygenated with three freeze-pump-thaw cycles, and then backfilled with nitrogen. The flask was opened briefly under a flow of N2, and freshly cut copper wire (1.0 cm length, 20 gauge) was added on top of the frozen mixture. The flask was resealed, evacuated for an additional 15 min, warmed to room temperature, and then backfilled with nitrogen. The mixture was stirred at room temperature until the solution became sufficiently viscous, indicating that the desired monomer conversion was reached (1-6 h). The flask was then opened to air and the solution was diluted with DCM. The polymer was precipitated into cold methanol (2×) and the isolated polymer was thoroughly dried under vacuum and characterized by GPC MALS.
Calculation of Activation Energies. Activation energies for model furfuryl carbonate and carbamate compounds were calculated using Spartan '18 Parallel Suite. All calculations were run with a solvent dielectric constant of 37.22. Equilibrium geometries and corresponding energies of each furfuryl carbonate or carbamate reactant were calculated at the M06-2X/6-311+G** level of theory with a fine integration grid (99,590). Transition state geometries were approximated using an initial energy profile at the HF/6-31+G* level of theory by lengthening the α-C—O bond involved in the desired fragmentation reaction. The energy maximum from each profile was then chosen as the starting point for a transition state geometry optimization, which was conducted at the same level of theory. Subsequent geometry optimizations were performed at the M06-2X/6-311+G** level of theory and the optimized structures were subjected to a final energy and frequency calculation at the M06-2X/6-311+G** level of theory using a fine integration grid (99,590). Each structure returned a single imaginary vibrational frequency corresponding to the expected bond-breaking mode.
CoGEF calculations. CoGEF calculations were performed using Spartan '18 Parallel Suite according to previously reported methods. Ground state energies were calculated using DFT at the B3LYP/6-31G* level of theory. Starting from the equilibrium geometry of the unconstrained molecule (relative energy=0 kJ/mol), the distance between the terminal methyl groups of the truncated structure was increased in increments of 0.05 Å and the energy was minimized at each step. The maximum force associated with the retro-Diels-Alder reaction was calculated from the slope of the curve immediately prior to bond cleavage.
General procedure for ultrasonication experiments. An oven-dried sonication vessel was fitted with rubber septa, placed onto the sonication probe, and allowed to cool under a stream of dry argon. The vessel was charged with a solution of the polymer in anhydrous acetonitrile/methanol (3:1 v/v, 2.0 mg/mL, 20 mL) and submerged in an ice bath. The solution was sparged continuously with argon beginning 20 min prior to sonication and for the duration of the sonication experiment. Pulsed ultrasound (1 s on/2 s off, 20% or 30% amplitude, 20 kHz, 8.2 W/cm2) was then applied to the system for 60 min (sonication “on” time), unless noted otherwise. Then the sonicated solution was filtered through a 0.45 μm syringe filter prior to analysis. For PMA-1, aliquots (1.0 mL) were removed at 0, 15, 35, 60, 90, 120 and 150 min (sonication “on” time) and filtered through a 0.45 μm syringe filter prior to analysis by GPC and fluorescence spectroscopy. Ultrasonic intensity was calibrated using the method described by Berkowski et al. in Ultrasound-Induced Site-Specific Cleavage of Azo-Functionalized Poly(ethylene glycol). Macromolecules 2005, 38, 8975-8978, the disclosure of which is incorporated herein by reference.
Analysis of sonicated polymer samples by fluorescence spectroscopy. Aliquots from the sonication experiments were added to a quartz microcuvette (Starna 18F-Q-10-GL14-S) and emission spectra were recorded at 340-500 nm using an excitation wavelength of λex=330 nm. Samples were then allowed to incubate at room temperature for approximately 20 h to allow for the complete decomposition of any furfuryl carbonate, and the emission spectra were remeasured with the same instrument parameters. Emission spectra were recorded using an excitation wavelength of 330 nm for PMA-1(O)-PMA-3(O) (hydroxycoumarin), and 365 nm for PMA-1(N)-PMA-3(N) (aminocoumarin).
The photograph of the sonicated samples, shown in the inset of
Calculation of Relative Response Factors (RRFs). A standard solution with known concentrations of the internal standard (IS) molecule and the small molecule analyte was prepared and analyzed by HPLC equipped with a UV detector. The RRF is calculated from the HPLC results of the standard solution using the following equation:
Determination of relative response factors (RRF):
Determination of the concentration of released payload molecules from polymers after ultrasound-induced mechanical activation. After 60 min of ultrasonication, a known concentration of internal standard (IS) was added into the solution of sonicated polymer. The solution was then kept at room temperature and analyzed by HPLC at various time intervals. The concentration of the released payload molecule (the analyte) in the solution was calculated using the following relationship:
Crystals for X-ray diffraction analysis were grown by slow diffusion of hexanes into a solution of compound 12 in chloroform/toluene (1:9 v:v). A crystal was mounted on a polyimide MiTeGen loop with STP Oil Treatment and placed under a nitrogen stream. Low temperature (200K; there were crystal issues at lower temperatures) X-ray data were collected with a Bruker AXS D8 VENTURE KAPPA diffractometer running at 50 kV and 1 mA (Cu Kα=1.54178 Å; PHOTON II CPAD detector and Helios focusing multilayer mirror optics). All diffractometer manipulations, including data collection, integration, and scaling were carried out using the Bruker APEX3 software. An absorption correction was applied using SADABS. The space group was determined and the structure solved by intrinsic phasing using XT. Refinement was full-matrix least squares on F2 using XL. All non-hydrogen atoms were refined using anisotropic displacement parameters. Hydrogen atoms were placed in idealized positions and refined using a riding model. The water molecule was refined as a rigid body. The isotropic displacement parameters of all hydrogen atoms were fixed at 1.2 times (1.5 times for methyl groups) the Ueq value of the bonded atom. Special refinement details: compound 12 crystallizes in the orthorhombic space group Pna21 (#33) with two molecules and one water molecule in the asymmetric unit. The structure was refined as a two component (0.55:0.45) inversion twin. In one molecule the Br is disordered with a CH3 group (0.69:0.31).
This description of the invention has been presented for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form described, and many modifications and variations are possible in light of the teaching above. The embodiments were chosen and described in order to best explain the principles of the invention and its practical applications. This description will enable others skilled in the art to best utilize and practice the invention in various embodiments and with various modifications as are suited to a particular use. The scope of the invention is defined by the following claims.
The present application claims priority under 35 U.S.C. 119(e) to U.S. Provisional Application No. 63/075,666 filed Sep. 8, 2020, and U.S. Provisional Application No. 63/171,889 filed Apr. 7, 2021, the disclosures of which are incorporated herein by reference in their entireties.
Number | Date | Country | |
---|---|---|---|
63171889 | Apr 2021 | US | |
63075666 | Sep 2020 | US |